Indices of zinc status in adolescent females by Sandoval, Wendy McGovern
JNDICES OF ZINC STATUS IN ADOLESCENT FEMALES 
By 
WENDY MCGOVERN SANDOVAL 
~ 
Bachelor of Science in Home Economics 
University of New Mexico 
Albuquerque, New Mexico 
1971 
Master of Science 
University of Nevada - Reno 
Reno, Nevada 
1972 
Submitted to the Faculty of the Graduate College 
of the Oklahoma State University 
In partial fulfillment of the requirements 
for the Degree of 
DOCTOR OF PHILOSOPHY 
July, 1982 
~~5/s, 
)q~~b 
5~1~ .1. 
c_op. ~ 
INDICES OF ZINC STATUS IN ADOLESCENT FEMALES 
Thesis Approved: 
··. · ' Thes'iTAdVfuri 
!.kt; ~·.IP= 
~~an of the Graduate College 
ii 
1143729 f 
ACKNOWLEDGMENTS 
Sincere appreciation is expressed to Dr. Mary Alice Kenney for 
her guidance and assistance throughout my graduate studies, especially 
in the development and completion of this research. Appreciation is 
also expressed to the other committee members, Dr. F. Owens, Dr. M. 
Scruggs, and Dr. E. Winterfeldt, for their invaluable assistance in 
the preparation of the final manuscript. In addition, appreciation is 
expressed to Dr. L. Reed, professor of Agronomy, Oklahoma State Uni-
versity, for assistance in completing the atomic absorption analysis 
of the erythrocyte samples. 
The encouragement and help of many friends along the way is 
gratefully acknowledged. Thanks are given to Andrea Arquitt, Barbara 
Alsup, Denise Graven, and Dr. Lea Ebro. 
My deepest thanks go to my family whose support, love, and en-
couragement helped me achieve this goal: my husband, Stann; my mother, 
Edith McGovern, my father, James E. McGovern, and my in-laws, Peggy 
and Jake Sandoval. 
iii 
Chapter 
I. 
TABLE OF CONTENTS 
INTRODUCTION 
Significance. 
Purpose • • • . 
II. REVIEW OF LITERATURE 
Zinc Absorption and Metabolism. 
Factors Influencing Zirtc Absorption • 
Zinc Requirements of Adolescent Females 
Dietary Zinc in Adolescent Females. 
Indices of Zinc Status. • • • 
Plasma and Serum Zinc. 
Hair Zinc. 
Urinary Zinc • • • • . . • • • • 
Erythrocyte Zinc Concentration • 
Plasma Ribonuclease. • • . • . 
Serum Alkaline Phosphatase • 
Summary • • • • • • 
III. METHODS AND PROCEDURES 
Sample Design . • • • . • • • • 
Procedures . ... , . . ....... . 
Dietary Intake Data. • . • • • 
Demographic and Socioeconomic Data . 
Anthropometric Data. . 
Clinical Data. • • 
Blood Collection 
Biochemical Analyses. 
Erythrocyte Zinc Concentration • . 
Plasma Ribonuclease •..• 
Serum Alkaline Phosphatase • 
Statistical Analyses. 
IV. RESULTS AND DISCUSSION •.. 
Description of the Sample • . • • • . . . • • 
Indices of Zinc Status. • . . . • • 
Zinc Intake and Related Dietary Compo-
nents. • • • • 
Erythrocyte Zinc Concentration • • • . 
iv 
Page 
1 
3 
3 
4 
4 
9 
14 
16 
18 
19 
22 
23 
23 
26 
30 
34 
35 
35 
35 
35 
36 
36 
37 
37 
38 
38 
40 
41 
42 
45 
45 
46 
46 
54 
Chapter Page 
Plasma Ribonuclease. . . • • • • • . . . . . 5 7 
Serum Alkaline Phosphatase . . • • . . • . 60 
Relationships Among Zinc Intake, Erythro-
cyte Zinc Concentration, Plasma Ribo-
nuclease Activity, and Serum Alkaline 
Phosphatase Activity • 64 
Summary and Recommendations 69 
V. SUMMARY .. 
A SELECTED BIBLIOGRAPHY 
APPENDIXES. . . . • . . 
APPENDIX A - LIST OF ABBREVIATIONS IN COMPUTER PRINT-
OUTS AND COMPUTER LISTS OF RAW DATA BY 
73 
76 
89 
MENARCHEAL STATUS . . . . . . . • . 90 
APPENDIX B - STEPWISE REGRESSION MODELS FOR ZINC 
INTAKE. . . . . . . . • • . . . . . 95 
APPENDIX C - STEPWISE REGRESSION MODELS FOR ERYTHRO-
CYTE ZINC CONCENTRATION • . . • . . . 99 
APPENDIX D - STEPWISE REGRESSION MODELS FOR PLASMA 
RIBONUCLEASE. . . . . . • • • . . . . . . 105 
APPENDIX E - STEPWISE REGRESSION MODELS FOR SERUM 
ALKALINE PHOSPHATASE. . • • . • 111 
APPENDIX F - FIGURES 3 THROUGH 13. 117 
APPENDIX G - STEPWISE REGRESSION MODELS WITH "FORCED" 
VARIABLES . . . . . . . • • • . . . • . . 129 
v 
LIST OF TABLES 
Table Page 
I. Numbers of Subjects by Age, Race, and Menarcheal 
Status. . . • . • • • • • • • • • 46 
II. Least Squares Mean Intakes of Zinc, Total Protein, 
Animal Protein, and Energy by Menarcheal Status, 
and by Age and Race, According to Menarche. . • • • 48 
III. Least Squares Mean Intakes of Total Protein, Animal 
Protein, and Energy by %-RDA-Zinc, According to 
Menarche. . . . . . . . . . . . . . . . . . . . 50 
IV. Comparison of Mean Dietary Zinc, Protein, and Energy 
From Selected Studies • . • . • . . • • • • • • 53 
V. Least Squares Mean of Erythrocyte Zinc Concentration 
by Menarcheal Status, and by Age and Race, Accord-
ing to Menarche • . . • . • . • • . . • . . • . . • 55 
VI. Least Squares Mean Erythrocyte Zinc by %-RDA-Zinc, 
According to Menarche . . . • . . . • • . • . 56 
VII. Least Squares Mean Plasma Ribonuclease by Menarcheal 
Status, and by Age and Race, According to Men-
arche . . . . . . . . . . . . . . . . . . . . . . . 58 
VIII. Least Squares Mean Plasma Ribonuclease by %-RDA-Zinc, 
According to Menarche • • • • . • • • • 59 
IX. Least Squares Mean Serum Alkaline Phosphatase by 
Menarcheal Status, and by Age and Race, According 
to Menarche . . . . . . . . . . . . . . . . 61 
X. Least Squares Mean Serum Alkaline Phosphatase by 
%-RDA-Zinc, According to Menarche . . • . . 63 
XI. Comparison of Mean Sertnn Alkaline Phosphatase Values 
With Selected Studies • • • . • • • • . • • 65 
XII. Least Squares Mean for Indices of Zinc Status by 
Erythrocyte Zinc, According to Menarche 67 
XIII. Multiple Regression Analyses for Selected Models 
With "Forced" Variables • . • • . . • • . • • • 68 
vi 
LIST OF FIGURES 
Figure Page 
1. Scattergram of Serum Alkaline Phosphatase and Months 
Past Menarche. • • • . • • • • • • • • . • • • . . 62 
2. Scattergram of Serum Alkaline Phosphatase and Zinc In-
take for Post-Menarche Subjects. • • • • • • • • 66 
3. Scattergram of Erythrocyte Zinc Concentration and Zinc 
Intake for Pre-Menarcheal Subjects • • • • • • • . . 115 
4. Scattergram of Erythrocyte Zinc Concentration and Zinc 
Intake for Post-Menarcheal Subjects. • • • • . . 116 
5. Scattergram of Plasma Ribonuclease and Zinc Intake for 
Pre-Menarcheal Subjects. . . . . . . . . . . 117 
6. Scattergram of Plasma Ribonuclease and Zinc Intake for 
Post-Menarcheal Subjects . . . . . . . . . . 118 
7. Scattergram of Serum Alkaline Phosphatase and Zinc 
Intake for Pre-Menarcheal Subjects • • • • . • • 119 
8. Scattergram of Serum Alkaline Phosphatase and Plasma 
Ribonuclease for Pre-Menarcheal Subjects • • • • • 120 
9. Scattergram of Serum Alkaline Phosphatase and Plasma 
Ribonuclease for Post-Menarcheal Subjects. • • • • 121 
10. Scattergram of Serum Alkaline Phosphatase and Erythro-
cyte Zinc Concentration for Pre~Menarcheal Sub-
jects. • •• 
11. Scattergram of Serum Alkaline Phosphatase and Erythro-
cyte Zinc Concentration for Post-Menarcheal Sub-
122 
jects. . . . . . . . . . . . . . . . . . . . 123 
12. Scattergram of Plasma Ribonuclease and Erythrocyte Zinc 
Concentration for Pre-Menarcheal Subjects. • • . 124 
13. Scattergram of Plasma Ribonuclease and Erythrocyte Zinc 
Concentration for Post-Menarcheal Subjects • . . 125 
vii 
CHAPTER I 
INTRODUCTION 
The essentiality of zinc for humans had been suggested by Todd 
in 1934 (1). The intake of zinc was not considered a problem, how-
ever, until clinical manifestations of zinc deficiency were identi-
fied in the early 1960's. The severe growth and sexual retardation 
found in adolescent males in Egypt (2) and Iran (3) was thought to 
be a result of zinc deficiency. Supplementation of the diet with 
oral zinc sulfate resulted in rapid growth and sexual maturation of 
these Egyptian adolescents (4). These findings were confirmed when 
Iranian dwarfs, fed a well-balanced, zinc-supplemented diet, had im-
proved growth and reached sexual maturation sooner than Iranian 
dwarfs fed the same diet without supplementation, thus identifying 
zinc deficiency as themajor cause of the endocrinopathies (3). 
The extreme dwarfism and lack of sexual maturation represented 
one end of the spectrum of types of effects of deprivation of zinc. 
The effects of mild zinc deficiency on outwardly healthy adolescents 
remains to be investigated, as zinc may be a limiting factor during 
periods of growth. Recent evidence suggests that marginal zinc de-
ficiency may be a problem in many nations, including the United States. 
The assessment of zinc status and intake of various populations 
in nutrition surveys has been limited. There is currently no stand-
ardized procedure for assessing zinc status in humans (5, 6). Analyses 
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of zinc concentration in commonly used materials such as blood, urine, 
and hair are currently being questioned as indices of zinc status. 
The identification of zinc as a component of more than 20 enzymes 
stimulated interest in the use of enzyme assays as a measure of zinc 
status. Because of the inadequacy of any one measure, the use of 
several indices to measure zinc status is considered imperative at 
this point in time (7). In addition, relatively easy-to-conduct pro-
cedures are essential for use in nutrition status surveys. 
Few data are available on the zinc intake of groups in the 
United States. Recent research provides evidence of marginal intake, 
relative to current recommendations, in segments of our population 
particularly in relation to low income (8) and low meat consumption 
(8, 9). Future surveys of populations considered to be at nutritional 
risk need to assess the prevalence of marginal zinc intake. One of 
the groups of people identified by nutrition surveys to be at nutri-
tional risk generally is teenagers. Dietary studies for that group 
have shown low intakes of calcium, iron, vitamins A and C, and ribo-
flavin (10, 11). Little information on dietary zinc was collected 
because standard food composition references did not include zinc 
content of foods. Although analyses of dietary intake indicated 
teenagers had lower intakes of various nutrients than were recommended, 
the reconnnendations for nutrient needs of adolescents are based on 
limited data, especially for protein, calcium, iron, zinc, magnesium, 
fluoride, iodine, and for vitamins D and C, riboflavin, and thiamin 
(12). As adolescence is a period of increased nutrient needs due to 
the demands for growth, zinc intake should be further investigated in 
relation to present reconnnendations. 
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Significance 
Little information is available on zinc intake or status of ado-
lescent females. In a recent study on trace mineral status, Greger 
et al. (13) reported that one-third of the adolescent girls consumed 
less than two-thirds of the Recommended Dietary Allowance (RDA) for 
zinc. However, only 3% of the girls were considered to be in marginal 
zinc status based on hair and plasma zinc levels. Indices of zinc 
status for adolescents, such as erythrocyte zinc, plasma ribonuclease, 
and alkaline phosphatase, have received little examination. Reliabil-
ity of present and proposed indices needs to be determined before 
dietary records can be reevaluated. Consideration of the measurements 
best suited for nutrition status surveys is important, as information 
on relatively large samples needs to be obtained. Therefore, relating 
dietary zinc intake to indices of zinc status is an extremely impor-
tant area for research. 
Purpose 
The purpose of this research was to determine the means and ranges 
of values for zinc intake, erythrocyte zinc concentration, plasma 
ribonuclease activity, and serum alkaline phosphatase activity among 
adolescent females according to age, race, and menarcheal status. In 
addition, the relationships among erythrocyte zinc concentration, 
plasma ribonuclease activity, serum alkaline ·phosphatase activity, 
and zinc intake were investigated. The practicality of these proposed 
measures of zinc status for use in nutrition surveys was assessed. 
CHAPTER II 
REVIEW OF LITERATURE 
The reports relating zinc intake to impaired growth and sex-
ual maturation, and depressed levels of various parameters of zinc 
status stimulated considerable research (2, 3). The World Health Or-
ganization (WHO) challenged nutrition scientists to intensify their 
research on trace element status of populations in 1973 (14). Spe-
cific reconnnendations included developing indices or parameters for 
measuring zinc status and assessment of the occurrence of zinc de-
ficiency in all populations. Since then, the importance of zinc in 
nucleic acid metabolism (15), taste perception (8), wound healing 
(16), and the treatment of acrodermatitis enteropathica (17) has 
been identified. However, estimations of zinc status of many healthy 
populations, including adolescent females, have been limited. 
The following presents information on the absorption and metab-
olism of zinc. Data on the requirement for zinc and zinc intake of 
adolescent females were reviewed. In addition, various methods used 
in assessing zinc status and their applicability to nutrition status 
surveys were evaluated. These include measures of serum and plasma 
zinc, hair zinc, urinary zinc, erythrocyte zinc, and zinc-related 
enzyme activities. 
Zinc Absorption and Metabolism 
The factors affecting zinc metabolism are not well understood. 
4 
The process and control of absorption of zinc and the factors that 
may enhance or hinder these processes are being studied. Research 
indicates that the bioavailability of zinc is a major factor in the 
maintenance of zinc status. 
The primary site of zinc absorption is still under investiga-
tion, as few studies have been conducted with animals or humans. 
Pearson et al. (18) used everted gut sacs from rats and found ab-
sorption occurred primarily in the distal portion of the small in-
testine, by active transport. However, zinc absorption was greater 
from the duodenum than the distal portion of the small intestine in 
two studies using ligated rat intestinal sacs (19, 20). 
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The absorption of zinc in humans was measured using the intesti-
nal perfusion technique (21). Four volunteers, ages 21 to 32, con-
sumed four different meals on four consecutive days. Duodenal and 
jejunal samples were collected at three sites every 10 minutes from 
each subject for one hour prior to and five hours after each treat-
ment. The blended meals had different compositions but were iso-
caloric (464 kcalories) and of similar fat content (21.0 g), volume, 
osmolality, and pH. Meal A contained 24.0 g protein, primarily from 
beef, and provided 7.5 mg iron and 4.4 mg zinc. Meals B, C, and D 
contained 14.8 g protein, mostly from a specially prepared breakfast 
cereal and milk. Mineral contents were 1.4 mg iron and 2.4 mg zinc 
(B); 5.3 mg iron and 5.5 mg zinc (C); and 4.6 mg metallic iron and 
5.5 mg zinc (D). Iron disappeared from the intestinal juices at 
sites in the duodenum and proximal jejunum, with little change in 
iron content of juices in the distal jejunum. The bioavailabilities 
of the different forms of iron and with different meals were similar. 
Sites of zinc absorption were difficult to measure as more zinc was 
found in the intestinal contents recovered from the duodenal juices 
than was present in the meal, indicating a mixture of endogenous 
and exogenous zinc. Recovery peaked at all three sites during the 
first two hours and was similar for all meals. The sites of zinc 
absorption were not identified. Further studies need to be con-
ducted to determine the site(s) of zinc absorption. 
Studies on zinc absorption reported wide ranges of estimations 
of efficiency. Most studies estimated retention by measuring the 
difference between intake and fecal and urinary output. Few studies 
measured zinc loss in sweat or in sloughed cells. Differences in 
efficiency of absorption may be due to type of zinc used, methods 
of administration, techniques for measuring absorption, and individ-
ual variation. Mean absorption of 38 percent of a single dose of 
70zn (3.6 mg 70zn of 11 mg in the diet) was measured in 22 women 
consuming a semi-purified formula diet (22). 70 The Zn was given on 
day four of the 12 day metabolic study. Average absorption of 36 
percent was found in five healthy male subjects given an oral dose 
of 15 to 24 µCi 65zn consuming an analyzed diet for 24 days (23). A 
range of absorption of 40 to 86 percent of an oral dose of 10 µCi 
carrier free 65 zn was measured two hours after administration to 75 
subjects in a fasting state, using the total body counting tech-
nique (24). Information on zinc retention in subjects consuming 
mixed diets is lacking. An estimated efficiency of absorption of 
dietary zinc between 20 to 40 percent has been estimated by the 
WHO (14) and 40 percent by the National Research Council (25). 
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A number of theories exist regarding the homeostatic control of 
zinc absorption. The presence of a low-molecular-weight zinc bind-
ing ligand (LMW-ZnBL) in intestinal secretions is under consider-
able debate. A number of investigators have identified various 
LMW-ZnBL involved with zinc absorption, including prostaglandins 
(26), citric acid (27, 28), and picolinic acid (29). In addition, 
several investigators provided evidence of LMW-ZnBL in human milk 
which were indistinguishable from LMW-ZnBL isolated from intestinal 
secretions (28, 30, 31). Additional support for LMW-ZnBL was pro-
vided when a qualitative defect in the binding affinity of LMW-ZnBL 
containing fraction of human pancreatic secretions in patients with 
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acrodermatitis enteropathica (AEP) was reported (32). Cousins et al. 
(33), however, have questioned the presence of a IMW-ZnBL. They 
found no evidence of any LMW-ZnBL in freshly prepared samples of rat 
intestinal cytosol after oral administration of 65 zn. Considerable 
amounts of IMW-ZnBL were found when samples were kept at 37°C for 
30 minutes or 5°C for one hour. These data suggested that intesti-
nal LMW-ZnBL were products of the isolation procedure rather than 
products of intestinal secretions (33, 34). Thus, the site of ab-
sorption and the mechanism of action of zinc uptake are not entirely 
understood. 
Zinc transport across the mucosa! membrane is probably by ac-
tive transport (18, 35). The proposed homeostatic regulation of 
zinc includes a mucosal block or feedback regulation of absorption 
(34). The zinc may become part of cellular high molecular weight 
zinc metalloproteins, transferred to the plasma, or bound to metal-
lothionein (34). Metallothionein is assumed to be an intracellular 
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binding protein, rich in sulfur amino acids, that binds excess zinc 
and traps it within the cell. When the mucosal cells are sloughed, 
the zinc returns to the lumen. In an experimental study using 
laboratory animals, metallothionein increased when additional zinc 
was administered by diet or parenterally (36). 
Carrier proteins of zinc in the plasma from the intestinal 
tract to the liverweredifferent in several studies. Cousins et al. 
(33) and Suso et al. (37) identified albumin as the main carrier 
protein in portal blood, while Evans et al. (38) identified trans-
ferrin as the major portal transport protein. 
Limited data exist on the metabolism of zinc in humans. The 
major route of excretion is the feces, with urinary excretion rela-
tively independent of zinc intake. In a series of studies on zinc 
b 1 . 65z d · · d · 1 11 t meta o ism, n was a ministere , intravenous y or ora y, o 
patients suffering from a variety of chronic diseases (24, 39, 40). A 
single dose of labeled zinc chloride (ZnC12) was given intravenously 
to eight patients and the 65zn content of whole blood, plasma, urine, 
and feces was measured for 45 days (39). Thirteen minutes after in-
jection, the blood contained 42 percent of the dose, with the plasma 
showing 20 percent activity. After one hour, the whole blood con-
tained only five percent of the dose. The plasma level declined and 
stabilized by the tenth day with 0.7 percent of the dose, while the 
whole blood concentration declined to three percent and remained 
stable for the remainder of the period. The excretion via the feces 
initially was five percent and increased to 20 percent. The urinary 
excretion was independent of the blood concentration. Similar find-
ings were reported by Graig et al. (41). 
Blood zinc peaked between two and four hours following an oral 
dose of 15 to 25 uC.i 65zn (23). Initially, plasma 65 zn was higher 
than that in whole blood. The level in whole blood increased for 
five days and then declined, while the plasma level consistently 
decreased after four hours. Sixty-six percent of the tracer dose 
was excreted in the feces in the first three days. After 21 days, 
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70 percent of the dose was accounted for in the feces and two percent 
in the urine. Increased amounts of urinary zinc were found when 
chelating agents were given to patients who had previously received 
65 zn (40). 
The distribution of zinc in the tissues was measured during 
autopsy in 11 patients with metastatic neoplastic disease, following 
an intravenous dose of 65 zn (39). Zinc uptake was highest in the 
liver, kidney, and spleen. The uptake by the pancreas, adrenals, 
and thyroid was high, but slower than the previously mentioned or-
gans. The concentration in the large and small intestine was high, 
while concentration in muscle tissue was low. 
The mixture of endogenous and exogenous zinc must be considered 
in attempts to estimate true absorption as well as in assessing fac-
tors that may influence absorption, such as level of zinc in the 
diet, and dietary factors. Additional research is needed to deter-
mine whether changes in fecal zinc reflect differences in efficiency 
of absorption or changes in endogenous zinc status. Information on 
the absorption, transport, and metabolism of zinc is needed for im-
proved evaluation of the zinc status of populations. 
Factors Influencing Zinc Absorption 
A number of factors are known to influence zinc absorption. 
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These include phytate, calcium, and other dietary components. In 
several animal studies, poor growth and other evidence of zinc defi-
ciency developed in animals fed diets composed largely of plant pro-
teins. O'Dell and Savage (42) fed young chickens casein- or soy-based 
diets and feeds treated with phytic acid. The effects of zinc supple-
mentation of 9 ppm and 15 ppm to both conventional feeds and phytic 
acid-treated feeds were measured. The growth of the casein-fed chic-
kens was used as the standard. Supplementation of the casein diet did 
not enhance growth, indicating zinc intake was adequate. Birds fed soy 
protein grew slower than the casein-fed birds, but supplementation of 
the soy feeds with 15 ppm zinc produced growth equal to those fed 
casein. Phytate reduced growth in birds fed either treated soy or 
casein; however, addition of 15 ppm zinc along with the phytate re-
sulted in growth equal to the standard. Isolated soy protein contained 
less available zinc than the casein protein and zinc availability was 
further reduced by phytic acid in both. Pigs fed soy versus casein 
diets (43, 44) and rats fed soy versus casein or egg white diets (45) 
showed similar responses to supplemental zinc as the chickens above. 
A negative effect of phytate on zinc status had also been noted 
in humans consuming moderate zinc intakes. The phytate content of 
the diet consumed by Iranian dwarfs was identified as a major cause 
of zinc deficiency (46) and zinc supplementation of the diet resulted 
in improved growth (3). The incidence of dwarfism was higher in 
Iranian villagers than Iranian urban dwellers, even though the esti-
mated zinc content of both diets was 12 to 15 mg/day (47). Reinhold 
et al. (47) speculated that the difference was due to the phytate 
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content of the bread consumed by the villagers. The phytate content 
of Tanok, the unleavened wholemeal bread staple of the villagers, 
was greater than the phytate content of the leavened bread of the 
urban dwellers. Tanok had a greater negative effect on zinc, cal-
cium, and nitrogen balance than purified bread with added sodium 
phytate (48). 
Additional factors thought to interfere with zinc absorption 
include calcium, phosphate, and mixtures of food. The responses of 
serum zinc to the oral administration of zinc sulfate (Znso4) with 
various substances were compared to determine the effect on zinc 
absorption. Healthy volunteers were given various levels of Znso4 
with either water, coffee, sodium phytate (102 mg phytate), sodium 
phosphate (48 or 480 mg phosphorus), and combinations of sodium 
phytate with 500 mg calcium and sodium phosphate with 500 mg cal-
cium (49). In addition, some of the subjects were divided into two 
groups. They were fasted overnight before receiving each of three 
different test meals, five days apart. The control meals contained 
coffee, dam, butter, and either brown bread (102 mg phytate), or 
white bread (4 mg phytate). The other meals contained milk and cheese 
or water and dry meat, plus the food in the controls. Blood was drawn 
before the test feeding and at two hours after the purified substances 
and at one, two, three, four, six, and nine hours after all other 
treatments. A peak lower than that found with 50 mg Znso4 and dis-
tilled water indicated a negative effect of the substance(s) on zinc 
absorption. Due to the variations within the study, direct compari-
sons were not made with all treatments; however, some general state-
ments were made. Consumption of the zinc along with coffee, all meals, 
and sodium phytate or phosphate gave lower peaks in serum zinc con-
centration compared with zinc administered with distilled water. 
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The addition of calcium to the purified substances showed inconsistent 
results. Meals containing the milk and cheese showed lower peak in 
serum zinc compared to the other meals, regardless of the phytate 
content. All meals containing 102 mg phytate have lower peaks than 
meals with 4 mg phytate. Similar peaks were found for meals with 
without meat. Consumption of zinc with dairy products, brown bread, 
purified phytate, or phosphate showed lower peaks in serum zinc, with 
dairy products having the most negative effect. 
The greater response of serum zinc to an oral dose of Znso4 with 
water than with various substances supported the theory that dietary 
components interfered with zinc absorption. Studies measuring true 
absorption are needed to demonstrate the extent of the inhibitory ef-
fect of connnon foods and substances in a "typical" U.S. diet on uptake 
of dietary zinc. 
Additional research on plant-based diets and zinc status involved 
investigation of the effects of a lacto-ovo vegetarian diet on plasma 
zinc and zinc content of whole mixed saliva or saliva sediment in 12 
non-vegetarian females (50). Fasting plasma zinc was measured in all 
12, and whole mixed saliva was analyzed for seven subjects, and saliva 
sediment was analyzed for five subjects. The plasma response to an 
oral dose of 50 mg zinc, given as 220 mg Znso4 , was determined for 
seven subjects. All measurements were taken before and after three 
weeks on a vegetarian diet. The meals contained an average of 15.3 
+ 3.5 mg zinc; 7.8 .± 1.7 g crude fiber; 1756 .± 534 mg calcium; and 
4638 + 1322 mg phytate; and met or exceeded the 1974 RDA for all 
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other nutrients. Zinc content of the saliva sediment was lower 
after the diet than before. No change was found in the zinc con-
tent of the whole mixed saliva; however, the plasma response to the 
oral dose of zinc was greater after subjects consumed the vegetarian 
diet than before. This change was assumed to reflect increased in-
testinal absorption of zinc. These results supported the existing 
data on the negative effect of plant-based, high-calcium, high-
phytate diets on zinc status. 
The effects of calcium on zinc metabolism, with and without 
added phytate, were investigated in animals and humans. Weanling 
pigs fed twice their calcium requirement (1.2% diet) and zinc at 
30 ppm had decreased feed consumption, with low feed efficiency, 
poor growth and dermatosis, compared to weanling pigs fed 1.2% cal-
cium and 94 ppm zinc (51). The additional zinc overcame most of the 
negative effects of this high calcium feed. Weanling rats fed combi-
nations of 0.8% or 1.2% calcium, 12 ppm zinc, and 0.4% or 2.0% phytic 
acid had slower growth than rats fed the same combinations except with 
65 ppm zinc (52). Different levels of calcium (0.8 or 1.2%) without 
phytate had no negative effects on growth at either zinc levels. 
The effects of low and high dietary calcium, with and without 
phytate, was measured in five male subjects living in a metabolic 
ward (23). Zinc concentrations in plasma, whole blood, feces, and 
urine were monitored after an oral dose of 65zn. The diet contained 
an average of 2223 kcal, 258 mg calcium, 771 mg phosphorus, and 
15 mg zinc. During the second trial, calcium gluconate was added 
to increase the calcium to 1981 mg/day. Both diets were fed for 28 
14 
days. Similar absorption of the 65zn was found in both trials. 
The possible inhibition of zinc absorption with high calcium intake, 
by stimulating more zinc-phytate complexing, as proposed by several 
researchers, needs additional investigation as results are now 
confusing. 
Zinc Requirements of Adolescent Females 
Although data on human zinc requirements have been collected 
almost 40 years, there have been few observations of adolescent fe-
males. The requirement for a nutrient is the "minimum intake that 
will maintain normal function and health" (25, p. 3). The balance 
method was the principal technique employed in estimating zinc re-
quirements and was based on the difference between intake and fecal 
and urinary excretion. 
Zinc balance or net retention of zinc was reported for subjects 
on wide ranges of zinc intakes. Zinc retention in three male subjects 
fed specified levels of zinc, from 4.9 to 22.9 mg/day, for four-day 
periods, varied from -0.l to +2.7 mg (53). Positive balance occurred 
with higher zinc intakes. During a 30-day balance study, nine women, 
ages 19 and 20, consumed 11.2 ±. 2.6 mg zinc/day from mixed foods (54). 
The diets were based on five-day cycle menus. Four subjects were in 
slightly negative balance; one was in equilibrium; and four were in 
positive balance. Positive balance was measured in four women during 
a 27-day metabolic study consuming meat loaf, ice cream, tea, coffee, 
and orange juice (55). The zinc intake ranged from 16.1 to 20.9 mg, 
depending on food intake. Only one study reported a large apparent 
retention of zinc. Thirteen females, ages 17 to 27, retained an 
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average of 6.6 mg zinc on self-selected diets containing 9.8 to 14.4 
mg zinc/day (56). The large retention was unexplained. Based on 
these studies, zinc intake of 12 mg/day was suggested for adults to 
maintain equilibrium (23, 24, 54). 
Engel et al. (57) estimated preadolescent females needed to con-
sume 6 mg zinc/day to maintain equilibrium or positive balance. 
Thirty-six females, ages 7 to 10, were involved in a 30-day metabolic 
study. Various diets were consumed for six day periods with the pro-
tein ratio varied from 74% animal : 26% plant to 100% plant protein. 
The dietary zinc varied from 4.6 to 9.3 mg/day, with the higher levels 
associated with higher animal protein. Zinc retention of 14% was 
found, with little differences in types of protein or zinc levels. 
The effects of different levels of calcium and protein on zinc 
balance were measured in 15 preadolescents (58). Combinations were 
25 or 45 g protein; 260 or 620 mg calcium; and 4.8 or 6.9 mg zinc. 
Each diet was fed for six days and apparent absorption was measured. 
More zinc was retained on 46 g protein (27%) versus 25 g protein (14%) 
diet, which is in contrast to the balance study mentioned earlier 
(56). Few differences were found in zinc retention between the low 
and high calcium levels' at either protein level. 
Only one study measured zinc retention in adolescent females be-
tween 12.5 and 14.5 years old (59). Fourteen subjects consumed diets 
with two levels of zinc (7.4 and 13.4 mg/day) and defatted soy substi-
tuted for 15% and 30% of the meat at lunch. Urinary zinc excretion 
was similar to those for preadolescents (57, 58) and adults (60), re-
gardless of soy or zinc level. Fecal zinc was greater when subjects 
consumed 13.4 mg zinc than with 7.4 mg zinc, regardless of soy level. 
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Sixty-four percent of the subjects were in negative zinc balance on 
7.4 mg zinc, compared to "40% on 13.4 mg zinc, indicating more girls 
achieved equilibrium or positive balance on higher zinc intake than 
on the lower zinc intake. Additional data on zinc balance of adoles-
cent females is needed. Growth velocity peaks just prior to menarche 
(12) and increased zinc may be needed to maintain positive balance 
during this time. Investigation of the difference between pre- and 
post-menarcheal girls regarding zinc balance is needed. 
True absorption of zinc of 2.5 to 4.0 mg/day has been estimated to 
support growth and maintain zinc equilibrium for children and adults 
(14). The balance studies with preadolescents and adults indicated 
dietary intakes of 6 mg and 12 mg/day, respectively, were needed to 
maintain equilibrium or positive zinc balance. As these studies did 
not account for the zinc lost in sweat and in sloughed cells, the 
RDA was set at 10 mg/day for children 1 to 10; 15 mg/day for all other 
males and females; at 20 mg/day for pregnant females; and 25 mg/day 
for lactating females in 1974 (25). No changes were made in the 1980 
RDA for zinc (61). Additional evaluation of the zinc requirements of 
populations is necessary. Evaluation of the bioavailability of zinc 
from different foods needs to be investigated. For adolescent fe-
males, the relationships among dietary zinc, parameters of zinc 
status, and growth need to be studied in order to expand the infor-
mation to assess zinc status. 
Dietary Zinc in Adolescent Females 
Studies on the zinc intake of populations were limited in part 
because of the lack of data on zinc content of foods. Expanded 
information became available in recent years and stimulated evalua-
tion of diets for zinc content. 
17 
The zinc content of self-selected diets of females reported in 
published research ranged from 1.0 to 21.7 mg for one day. The zinc 
content of one-day diet records of 13 females, ages 17 to 27, ranged 
from 11.8 to 14.4 mg (56). The zinc content of 48 one-day diet 
composites collected from 15 adolescents (ages 14 to 16), living at 
home, was 1.0 to 19.0 mg and for 21 women (ages 18 to 30), living at 
home or in university dormitories, was 4.8 to 21.7 mg (62). 
The zinc to energy ratio of the diets, reported by White (62) for 
adolescents, was 8.6 .± 4.5 mg/1000 kcal; for adult women, 8.8 .± 2.6 
mg/1000 kcal. The zinc content of metabolic diets was 11.2 .± 2.6 mg 
(54), and the zinc to energy ratio was 6.6 mg/1000 kcal (63). Zinc 
levels in the metabolic diets were higher in diets containing beef or 
liverwurst than in diets containing turkey or ham (63). No explana-
tion for the higher zinc to energy ratio of the self-selected diets -
was given. 
Comparison of one-day diet records collected in the fall and 
spring from 184 adolescent females, age 12.8 .± 0.8, showed no sea-
sonal variation in zinc intake, with 11.3 .± 14.1 and 11.3 .± 4.7 mg, 
respectively (13). Although 39% of the girls in the fall and 36% in 
the spring consumed less than two-thirds of the 1974 RDA for zinc, 
all subjects had hair zinc concentrations within the normal range 
(.::_ 100 µg/g). The serum zinc concentration, measured in a sub-group 
of 94 girls, was also at the normal level. Only 3% of the sub-group 
had low serum zinc levels. These girls were similar to the total 
sample in all other measurements except for serum zinc. There was no 
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difference in either indicator of zinc status between pre- and post-
menarcheal girls. The question of whether hair and serum zinc con-
centrations reflected zinc status was unanswered. 
The mean zinc content of 132 self-selected diet composites from 
22 subjects, analyzed by atomic absorption spectrophotometry (AAS), 
was 8.6 + 0.5 (SE) mg (64). Based on the analyzed zinc values, 68% 
of the subjects consumed less than two-thirds of the RDA for zinc. 
The calculated zinc to energy ratio was 4/1000. Zinc status was not 
assessed. Fourteen-day food consumption records kept by these sub-
jects showed low to borderline protein and energy intakes related to 
low zinc intakes. The diets described simply as having "large" 
amounts of beef and eggs contained more zinc than diets with other 
types of protein. 
Data obtained from diet composites and calculated from composi-
tion tables indicated a wide range in zinc intakes. Several studies 
reported more than one-third of the subjects consumed diets with 
zinc content less than two-thirds of the RDA for zinc. From the 
study on zinc balance in adolescents, this level may be marginal in 
meeting the requirements for some adolescents. Interpretation of 
the dietary data alone cannot be used to assess zinc status of pop-
ulations; however, the consistently low values indicate a need for 
further research on the relationship between dietary intake and zinc 
status, especially for adolescent females. 
Indices of Zinc Status 
Major technological advances in trace mineral analysis have been 
made in recent years. However, no single measurement is accepted as 
an indicator of zinc status. The indices most often used to eval-
uate zinc status included plasma and serum, hair, and urinary zinc 
levels. In addition, erythrocyte zinc and assay for zinc~ 
metalloenzymes have been suggested. 
Plasma and Serum Zinc 
The most widely used measure of zinc status is plasma or serum 
zinc level. However, concentrations of zinc in the blood are in-
fluenced by many factors, including serum albumin, steroids, and 
conditions under which the blood was drawn. 
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Plasma zinc is totally bound to protein, with 30 to 40% bound 
to an a-2 macroglobulin and 60 to 70% loosely bound to albumin (65). 
Some investigators demonstrated a linear relationship between serum 
or plasma albumin and zinc concentration in various disease states, 
including cirrhosis (66, 67), renal allotransplantation (68), and 
cystic fibrosis (69). However, Solomons et al. (70) found plasma 
zinc decreased while plasma albumin increased in a prospective study 
on the effects of unsupplemented total parenteral alimentation on 
plasma minerals. 
The role of zinc in human protein me.tabolism during total 
parenteral nutrition (TPN) was recently assessed (71). The concen-
trations of albumin, transferrin, prealbumin, and serum zinc were 
measured before and after zinc repletion of seven severely defi-
cient patients receiving TPN. Serum zinc concentration of ~ 50 µg/dl 
and presence of acrodermatitis were used as evidence of deficiency. 
Supplementation of TPN with zinc (220 mg zinc sulfate for adults, 
one to three times per day and 500 µg zinc/kg/day for pediatric 
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patients) was the sole nutritional therapy during the 22 day study 
period. Serum zinc concentration increased from 21.6 + 2.4 to 63.0 
± 8.0 µg/dl. The initially low levels of albumin, transferrin, and 
prealbumin returned to near normal during the treatment with the de-
gree of improvement correlated with the half-lives of the proteins. 
The prealbumin levels responded the most rapidly, indicating this 
measure best reflected short-term changes in protein metabolism. 
The influence of steroids on circulating plasma or serum zinc 
levels was investigated. Oral contraceptive agents (OCA) affected 
circulating zinc inconsistently. Differences may be due to types of 
OCA used, length of time on OCA, and variety of methods used to 
analyze circulating zinc. A higher, but not significantly different, 
mean plasma zinc level was found for 16 women on OCA for 19 days (189 
µg/dl) than for non-OCA users (134 µg/dl) or pregnant women (117 µg/dl) 
(72). However, other investigators reported significantly decreased 
plasma zinc during OCA use (73-76). Differences in results were also 
reported by two investigators using hair and plasma/or serum zinc mea-
surements. Deeming et al. (77) reported higher mean serum zinc (186 
µg/dl) and lower mean hair zinc (199 ppm) in seven non-OCA users, 
compared to seven OCA users (149 µg/dl and 233 ppm, respectively). 
However, in a larger study with 69 subjects, no differences in serum 
zinc or hair zinc were found between OCA users and non-users after 
three or six months of use (78). 
In addition to the factors mentioned above, the manner in 
which blood was drawn influenced plasma/serum zinc levels. Hemol-
ysis of the sample during extraction or processing caused an apparent 
increase in serum or plasma zinc values (79). In addition, zinc 
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concentration of the serum was approximately 16% greater than the 
plasma, probably due to hemolysis, platelet disintegration, and 
slightly greater dilution in plasma (79). Hemolysis increased zinc 
because 75 to 80% of the zinc in human blood is found in erythro-
cytes (80). Contamination of the sample from glassware, collection 
tubes, and rubber stoppers represented additional factors influencing 
plasma and serum zinc levels (81). 
Although several factors influence circulating zinc concentra-
tions, studies have shown serum and plasma zinc reflected zinc status. 
Solomons et al. (70) measured the plasma zinc concentration in 13 
patients with gastrointestinal disease receiving TPN. The TPN con-
tained only 0.3 - 0.4 mg zinc/liter, given at the rate of three liters/ 
day. Plasma zinc concentration declined during the treatment by an 
average of 4.9 µg/dl week, while plasma albumin increased. 
The effects of a mild zinc-deficiency state in humans were in-
vestigated (82). Four male volunteers received a semi-purified diet 
based on texturized soy protein. The daily zinc intake during zinc 
restriction for two patients was 2.7 mg/day (for 24 weeks) and for 
two other patients, 3.5 mg/day (for 40 weeks). During zinc reple-
tion, 30 mg zinc acetate was given for 12 or 8 weeks, along with the 
experimental diet, followed by an eight week period with the supple-
ment and a standard hospital diet. The zinc concentration in the 
plasma, erythrocytes, leukocytes, and urine decreased during both 
zinc restriction regimens and returned towards normal during zinc 
repletion. 
The simple determination of circulating zinc alone is insuf fi-
cient for assessing zinc status of individuals or groups. The large 
bulk of research on serl.llll and plasma zinc have identified factors 
that influence these measurements but additional indices of zinc 
status must be measured for a more complete picture. 
Hair Zinc 
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The zinc content of hair had been used by several investigators 
in assessing zinc status. Values < 70 ppm were found in zinc-deficient 
individuals (83). The zinc concentration of hair in 338 healthy sub-
jects ranging from birth to 40 years of age was determined by AAS (8). 
Mean values were: neonates, 174 ± 8 ppm; 3 months to 4 years, 88 + 
5; 4 to 17 years, 153 + 5; and 17 to 40 years, 180 ± 4. In this in-
vestigation, a number of young children with hair zinc values of 
2_ 70 ppm, who had a history of poor growth, appetite, and taste 
acuity were identified. In assessing the zinc status of low income 
preschool children, hair and plasma zinc, and alkaline phosphatase 
were measured for 148 children (84). The 74 low income children had 
less plasma and hair zinc than 74 middle income children; however, 
plasma and hair zinc concentrations were not correlated. 
In contrast to Hambidge's data (84), a negative correlation be-
tween hair zinc and serum zinc was found by Greger et al. (13). The 
serum and hair zinc concentrations and dietary zinc intake of 184 
adolescent females, mean age 12.8 ± 0.8, were measured in the spring 
and fall. Mean concentration of zinc in hair sampled during the 
spring was 216 + 64 and 191 + 36 ppm for hair resampled in the fall. 
No.values below 100 ppm were found. The mean serum zinc value of 94 
+ 15 µg/dl was reported for 102 subjects. 
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Additional considerations necessary in evaluating hair zinc con-
centrations include possible contamination of the sample from the 
environment, shampoo, and bleach. The content of hair zinc depends 
on the delivery of zinc to the root as well as the rate of hair 
growth. As zinc deficiency may also impair hair growth, the use of 
this measure requires careful interpretation (84). 
Urinary Zinc 
A number of problems limit the usefulness of urinary zinc as an 
index of zinc status. The standard procedure involves a 24-hour 
urine collection, which would impose significant problems in survey 
studies. Possibility of contamination is high and the biochemical 
analysis is complex and time consuming (6). In addition, both hypo-
zincemia and hyperzincuria were reported in various conditions associ-
ated with zinc deficiency .such as cirrhosis (67, 85) and TPN (86). 
The data on urinary zinc of populations have indicated that excre-
tion was independent of intake. 
Erythrocyte Zinc Concentration 
The zinc content of erythrocytes was first investigated by 
Vallee and Gibson (80). Using the dithizone method, a mean value of 
14.4 + 2.7 µg/ml packed red blood cells was determined by 31 healthy 
adults. The zinc content of erythrocytes of premature infants, full-
term infants, children up to 11 years of age, and adults was deter-
mined by Berferstram between 1948 and 1952 (87). A progressive rise 
from 3.8 + 1.1 µg in full-term infants to 11.53 ± 1.8 µg/ml at age 
11 was found. The value determined for 11 years of age was not 
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significantly different than a value of 12.4 ± 1.8 µg/ml obtained for 
adults. 
The zinc content of erythrocytes ranged from 10 - 14 µg/ml in 
various studies. Comparing the dithizone method and atomic absorp-
tion spectrophotometry in 14 normal adult male volunteers, no differ-
ences were found (14.0 + 1.5 and 13.7 ± 1.2 µg/ml, respectively) (88). 
Neither were differences found in fasting and postprandial erythro-
cyte zinc (10.l ± 1.2 and 10.1 ± 1.0 µg/ml) or plasma zinc (103 + 
13.4 and 104 ± 13.1 µg/dl) in 10 adult subjects (89). Mansouri 
et al. (90) found the zinc content of erythrocytes in 51 fasting 
adults to be 11. 8 ± 1. 7 µg/ml. 
Erythrocyte zinc content in various pathological conditions was 
reported. Measures of zinc status, including plasma, erythrocyte, 
hair, and urine zinc and activity of plasma ribonuclease were obtained in 
adult, sickle cell anemia patients (SCA), and in healthy, non-anemic 
adults (91). Mean values for plasma, erythrocyte, and hair zinc were 
lower in SCA than non-anemic adults, while mean urinary zinc excre-
tion and plasma ribonuclease activity were greater for SCA patients. 
After treatment with 660 mg zinc sulfate in nine patients (for vary-
ing periods of time), plasma zinc increased, while a trend toward 
increased erythrocyte zinc and decreased plasma ribonuclease activ-
ity was measured. In a three-year follow-up study on SCA, plasma, 
erythrocyte, and hair zinc remained lower than in healthy adults (92). 
Reduced erythrocyte zinc concentrations have been reported in 
primary zinc deficiency. Prasad et al. (2) reported reduced erythro-
cyte, plasma, and hair zinc in zinc~deficient dwarfs compared to 
normal Egyptian subjects. In addition, the removal of 65zn from plasma 
was more rapid in dwarfs, while urinary and fecal zinc were lower 
than in normal subjects. 
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Ronaghy and Halsted (93) presented a detailed report on the first 
cases of female dwarfs identified in Iran. The women, ages 19 and 
20, presented with the syndrome of dwarfism, hypogonadism, iron de-
ficiency anemia, and geophagia similar to the male zinc-deficient 
dwarfs (2, 3). Initial plasma zinc levels (40 and 29 µg/dl) in both 
patients were low and the erythrocyte zinc level measured in one 
patient was 5.5 µg/ml. Treatment consisted of a 2500 kcal diet 
based on the RDA, 100 mg ferrous fumarate, and 120 mg zinc sulfate. 
In one patient, all three components were given simultaneously. The 
plasma zinc rose to 111 µg/dl and erythrocyte zinc rose to 10.5 µg/ml. 
In the second case, diet and iron supplement were given for eight 
months. Plasma zinc rose to 78 µg/dl and erythrocyte zinc was 11.1 
µg/ml. The addition of zinc sulfate for three months resulted in a 
plasma zinc of 180 µg/ml and a greatly enhanced sexual maturity com-
pared to diet and iron supplementation alone. 
During a mild, dietarily induced zinc deficiency, erythrocyte 
zinc was measured during stabilization, depletion, and repletion (82). 
Erythrocyte zinc levels decreased in two patients after 12 weeks on 
a restricted diet containing 2.7 mg zinc/day and increased during the 
repletion stage, with 30 mg zinc, to slightly above the initial value. 
Two other subjects fed 3.5 mg zinc/day showed similar decrease and in-
crease in erythrocyte zinc; however, only one subject's values were 
significantly greater after repletion. As previously mentioned, 
plasma zinc decreased in all four subjects during zinc restriction 
and increased following supplementation. Additional parameters of 
zinc status were measured and were consistent with the diagnosis of 
mild zinc deficiency. 
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The use of erythrocyte zinc as a diagnostic tool in identifying 
zinc deficiency in humans has been suggested. Low erythrocyte zinc 
values may be indicators of long term rather than acute deficiency. 
The mechanism of zinc uptake by erythrocytes is not clearly under-
stood. Kruckeberg et al. (94) investigated the uptake of zinc by 
red cells in four different media: Krebs bicarbonate buffer (KBB), 
phosphate buffered saline (PBS), homologous plasma, and human serum 
albumin (HSA) in KBB. The zinc uptake by cells suspended in the KBB 
was 20 to 24 times more than by cells suspended in the other media. 
This indicated a major control of erythrocyte zinc was the environ-
ment or the medium. The KBB medium contained no zinc-binding consti-
tuent, whereas the plasma and PBS contained protein and phosphate, 
respectively, as zinc-binding constituents. Zinc efflux from eryth-
rocytes preloaded with high or low levels of zinc was small and 
independent of the pre-efflux zinc concentration. The zinc influx 
was much faster than the efflux, indicating that once zinc was as-
sociated with the cell it tended to stay. Other researchers found 
similar results (95, 96). 
No data are currently available on the zinc content of erythro-
cytes in adolescent females. Knowledge of the range of zinc content 
in erythrocytes for this age group is essential for this index to 
have general application in nutrition status surveys. 
Plasma Ribonuclease 
The severe growth retardation found in zinc-deficient animals 
27 
and humans stimulated research in identifying the biochemical changes 
associated with an inadequate supply of zinc. The effects of zinc 
deficiency on zinc content of tissues and enzyme activities of zinc-
deficient tissues in rats (97, 98) and in young pigs (99, 100) were 
investigated. The zinc content of various tissues was significantly 
lower in zinc-depleted animals versus pair-fed controls or ad 
libitum-fed controls. The ribonucleic acid (RNA) content of zinc-
deficient tissues of the young pigs was decreased, while the deoxyri-
bonucleic acid (DNA) content was similar to that of pair-fed or ad 
libitum-fed controls (100). In addition, growth retardation was 
noticed before the food intake was decreased in zinc-deficient ani-
mals. This early effect on growth led to the investigation of 
activity of zinc metalloenzymes associated with protein metabolism. 
Somers and Underwood (101) measured the zinc, RNA, DNA, and 
protein content and activity of ribonuclease (RNase) in the testes 
of zinc-deficient rats. An elevated RNase activity and lowered zinc, 
RNA, DNA, and protein content were found in zinc-deficient animals, 
compared to controls. The activities of RNase and deoxyribonuclease 
(DNase) in testes, thymus, kidneys, and bones of zinc-deficient rats 
were examined (103). The DNase activity showed no differences be-
tween pair-fed controls and zinc-deficient rats, whereas the activity 
of RNase was increased in zinc-deficient rats. Similar findings were 
reported by Fernandez-Madrid et al. (15). RNase degrades RNA to 3 1 -
mononucleotides. The action of RNase was completely inhibited by zinc 
ions at concentrations of 10-4 M (103). Thus, the zinc content of 
the cell regulated the activity of RNase, which, in turn, regulated 
the catabolism of RNA. An increased RNase activity led to decreased 
protein synthesis or increased protein catabolism and was partly 
responsible for the growth retardation observed in zinc-deficient 
animals (15, 101, 102). 
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Despite the increase in RNase cited in the above studies, 
Chesters and Will (104) found the activity of RNase unaltered in the 
liver, kidney, and testes; increased in thymus; and decreased in 
esophagus of the zinc-deficient animals compared to pair-fed controls. 
Also, the total RNase concentration and free RNase inhibitor concen-
tration were unaltered in the testes, kidney, and liver of both 
groups. The question of whether zinc deficiency alters RNase activ-
ity due to a direct effect of zinc on the enzyme system or as a gen-
eralized response to altered growth remains unanswered. 
The findings of altered RNase activity in zinc-deficient ani-
mals prompted investigation of this enzyme in humans. Comparison 
among studies was difficult because of differences in procedures 
used and expression of enzyme activity. Activity, in units/minute/ 
milliliter, indicated the difference in absorbance of the sample 
plus substrate minus absorbance of pre- or post-incubation controls. 
Increased RNase activity had been found along with other in-
dices of zinc deficiency in humans in a number of investigations. 
In patients with sickle cell anemia, the plasma RNase activity (4.4 
+ 0.02 units) was greater than for the control subjects (3.1 ± 0.01 
units) (91). Significantly lower plasma and erythrocyte zinc was 
found in the sickle cell anemia patients. After treatment with 
660 mg ZnS04 between 7 and 49 weeks in nine patients,. a rise in 
plasma zinc and a decrease in plasma RNase were found in five of the 
seven patients for whom complete data were available. 
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The activity of plasma RNase was higher during zinc depletion 
than during zinc repletion in all four subjects with mild primary 
zinc deficiency (32). Values for the two groups were 5.1 + 0.1 and 
7.3 + 0.1 units during depletion compared to 3.7 + 0.1 and 4.1 + 0.1 
units during repletion. These changes corresponded with the pat-
terns in plasma, erythrocyte, and urinary zinc concentrations. 
These results suggest that determination of plasma RNase activ-
ity is a useful parameter in the diagnosis and assessment of zinc 
status in humans. However, as a sole measure of zinc status, it is 
impractical, as altered levels have been found in other conditions. 
Higher serum RNase activity was found in weanling rats fed wheat 
gluten compared to rats fed animal protein (105). RNase activity 
decreased with increased nitrogen intake, indicating RNase activity 
may reflect protein status. 
In studies involving humans, elevated serum RNase activity was 
found in 10 of 14 patients with cirrhosis and in five of nine pa-
tients with leukemia (16). Elevated plasma RNase levels were mea-
sured in young children suffering from kwashiorkor compared to 
healthy, age-matched, well nourished children. After treatment, 
the levels for both groups were similar (107). Scott et al. (108) 
found elevated levels of plasma RNase in 14 low birth weight 
infants. 
Data on plasma RNase activity of normal, healthy subjects are 
limited. The plasma RNase activity, measured between birth and 10 
days of age in 10 healthy infants (12.1 ± 2.0 units), was higher 
than at 20 days of age (5.8 + 1.1 units) (107). The activity at 
20 days of age was not different than the mean value obtained on 
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10 subjects, ages 19 - 37 (5.7 + 0.7 units). A positive association 
between age and RNase activity was found when the mean value for 73 
subjects (mean age of 33) was compared to the mean value for 124 
subjects (mean age 78) (109). Lower serum RNase activity was re-
ported in individuals after a 20 minute exercise period than before 
exercise (110). 
No data exist on the plasma or serum RNase activity of adoles-
cent females. Assessment of the range of values for healthy females 
is essential in order to evaluate the implications for using this 
measure in nutrition status surveys. 
Serum Alkaline Phosphatase 
The presence of zinc in alkaline phosphatase (AP) was first 
demonstrated by Mathies (111). AP is classed as a zinc metalloen-
zyme with two to three g-atoms zinc per mole of enzyme required for 
catalytic activity (112-114). The physiological functions of AP 
are not well understood. The suggested roles for this enzyme, in-
eluding hydrolysis of phosphate esters, synthesis of phosphate 
esters, calcification, transport of substances across cell membranes, 
and regulation of cellular processes, are reviewed by Mccombs, 
Bowers, and Posen (115). 
Interpretation of reported AP activity is hampered because of 
the wide variety of assay methods resulting in different units in 
which activity is expressed. Expressing activity in terms of Inter-
national Units (IU), defined as the amount of enzyme that forms 1 
µrnol product/minute is recommended (116). However, the IU does not 
take into account differences in substrate concentration or pH; 
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thus, results from various studies expressed in IU have different 
numerical values. Conversion factors have been employed to convert 
activity expressed in one method to a different method; however, this 
must be done with caution, as results from experiments run under dif-
ferent conditions are not directly comparable. For purposes of this 
review, reported values were converted to Sigma (E) units for the 
convenience of the reader (115). 
A number of factors are known to influence serum alkaline phos-
phatase levels. Levels rose rapidly during the first few months of 
life and gradually declined throughout the first year, but remained 
higher than adult values (117, 118). The mean serum AP activities 
remained relatively unchanged from one year of age until puberty, 
with values consistently higher than adults (119-122). No signifi-
cant differences were found by sex between 6 and 10 years of age 
(119, 121-124). Most investigators noted a peak in serum AP values 
in females earlier than in males. Peak values were reported between 
11 and 12 years of age in preadolescent females (120); between 8 and 
12 years of age (3.23 to 3.73 E units/ml) in female British school 
children (121); in preadolescent females between 9 and 12 years of 
age (6.6 to 7.3 E units/ml); and at 11 years of age (6.2 ± 0.1 E 
units/ml) in low income preadolescent females (125). In an early 
report, no peak in serum AP was found in females ages 8 to 12 (124). 
A fa11 in serum AP was noted after the peak in the above mentioned 
studies, with a gradual lowering to adult values within six to eight 
years. For adolescent males, peak activity occurred approximately 
two years later than for females and gradually declined, but re-
mained higher than adult values at 18 years of age (120-126). 
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A number of dietary components are known to influence AP levels. 
The consumption of a diet high in sucrose (40% of kcal) increased 
serum AP values in males and females, compared with a diet containing 
40% of the energy from wheat starch (127). Protein malnutrition was 
associated with decreased AP values (128-131), as well as depressed 
plasma zinc levels (131). Serum AP varied little in volunteers in-
gesting 300 to 2000 mg calcium per day (132). Acute magnesium de-
ficiency in humans presented conflicting results (133-136). Patients 
suffering from hypophosphatemic osteomalacia had normal (135) or ele-
vated (136) serum AP activities. In vitamin D deficiency, resulting 
in rickets or osteomalacia, levels of AP were greatly elevated (137-
139). Serum AP was measured in surveys of the vitamin D status of 
populations (121, 140, 141) and in response to supplemental dietary 
treatment (142). 
In animal studies, AP was sensitive to zinc deficiency. In-
duced zinc deficiency resulted in a fall in tissue AP activities in 
chicks (143), turkeys (144), and rats (145). Serum AP decreased in 
rats (146, 147), pigs (148), and Holstein cattle (149) fed zinc de-
ficient rations. 
Depressed serum AP levels were reported in humans in both se-
vere and mild zinc deficiency. Low serum AP and low plasma zinc 
were reported in zinc-deficient Egyptian dwarfs (2). Zinc supple-
mentation of the diets of zinc-deficient Iranian subjects resulted 
in increased AP activity (3). In contrast, Carter et al. (150) 
found low plasma zinc levels, but normal serum AP in a group of 
adolescent Egyptian boys with evidence of mild growth retardation. 
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Low plasma zinc, serum AP, and erythrocyte zinc were found in a 
young female suffering from acrodermatitis enteropathica (AE) (151). 
The administration of zinc sulfate improved all three indices. Sim-
ilar findings were noted by Bohane et al. (152) in the treatment of 
an infant female suffering from AE. A positive correlation between 
serum zinc and serum AP in four patients with AE was reported (153). 
Kasarskios and Schuna (154) retrospectively evaluated the re-
sponse of serum AP in three patients who developed zinc deficiency 
while receiving total parenteral nutrition (TPN). Serum AP activi-
ties were within the normal range prior to zinc supplementation; how-
ever, activities rose above normal for 14 days. The values returned 
to normal for the remainder of the 28-day treatment period. A 
parallel decrease in serum AP and plasma zinc developed in children 
with clinical symptoms of zinc deficiency, while receiving unsupple-
mented TPN (155). Increased plasma zinc and serum AP followed sup-
plementation with zinc. Similar findings were reported by Principi 
et al. (156). 
Plasma AP was monitored carefully by Prasad et al. (82) in two 
males in whom a mild primary zinc deficiency was induced. The activ-
ity of the enzyme slowly declined when dietary zinc intake was 3.5 mg 
zinc/day. The activity nearly doubled during the eight week repletion, 
with zinc supplemented at 30 mg/day. 
The wide area of involvement of alkaline phosphatase in various 
disease conditions as well as its response to factors ranging from 
growth rate and age to dietary components other than zinc requires 
care in its use and interpretation. Consideration of these factors 
known to influence alkaline phosphatase is essential. Serum AP 
levels should be investigated in apparently healthy adolescent fe-
males in relation to the nutrient content of their diets and to 
other measures of zinc status for the best use of this measurement 
in clinical and nutritional assessment. 
Summary 
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The best clinical assessment of trace mineral deficiency is 
careful observation of the clinical response to supplementation of 
the nutrient under controlled conditions (5-7). Plasma zinc has 
been the most widely used measure of zinc status. The problems of 
obtaining appropriate samples for analysis of zinc has limited its 
use in surveys. For more widespread assessment of populations, 
however, less tedious and less expensive diagnostic procedures for 
zinc nutriture are desirable. Additional parameters suggested 
include melanosome zinc, carbonic anhydrase activity, retinol-
binding protein concentration, taste acuity, and leukocyte zinc. 
These measures have been reviewed by Solomons (6); however, their 
applicability for survey work remains to be investigated. As dis-
cussed previously, the use of erythrocyte zinc concentration, plasma 
ribonuclease activity, and serum alkaline phosphatase activity as 
indices of zinc status have been proposed. Their use in survey 
work seems feasible. This study investigated these three indices 
and zinc intake in a group of adolescent females. 
CHAPTER III 
METHODS AND PROCEDURES 
The status of adolescent females in regard to dietary zinc, 
erythrocyte zinc, plasma ribonuclease, and serum alkaline phospha-
tase was investigated. Recognition that adolescent females were 
a high risk group related to nutritional health, coupled with a 
paucity of data on their zinc status led to this investigation. 
Sample Design 
One hundred and fifty adolescent females, aged 11.5 to 16.5, 
participated in the S-150 Southern Regional Project on Nutritional 
Status of Adolescent Females, served as subjects for this study. 
The participants were selected from girls attending schools within 
a 70-mile radius of Stillwater, Oklahoma. Potential participants 
were contacted through the schools, Girls Scouts, or 4-H Clubs. 
Volunteers were provided with written and oral information about 
the study and the procedures. Each subject and a parent or guardian 
signed a written consent. Girls with known metabolic disorders were 
not utilized as subjects. 
Procedures 
Dietary Intake Data 
Two 24-hour recalls were obtained through personal interview by 
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trained survey aides. One record was obtained for the 24-hour period 
irmnediately preceding the collection of blood samples. The other 
record was collected at least two weeks prior to or two weeks after 
blood was drawn. Food models and various other aids were employed 
to increase the accuracy of estimations of food intakes. Information 
on types of foods commonly used at home was obtained during a personal 
interview with the parent or guardian. Nutrient totals from food and 
1 supplements were calculated using the Nutritional Analysis System. 
Demographic and Socioeconomic Data 
Through a questionnaire, data were obtained for each subject on 
age, race, education of subject and parents, number of persons in the 
household, and other background data. In addition, a measure of physi-
cal activity indicating type and intensity was obtained using a 
questionnaire. 
Anthropometric Data 
Anthropometric measures included height, weight, triceps skin-
fold, and arm circumference. Measurements were taken by trained sur-
vey aides. The height was measured, without shoes, with the subject's 
heels against a measuring board. The subject was asked to look di-
rectly forward, hold her head straight, and stretch to maximum height. 
The measurement was taken to the nearest quarter inch (157) and con-
verted to metric units. Height was expressed as a percentage rela-
tive to U.S. heights for age (158). 
1Nutritional Analysis System, Department of Experimental Statis-
tics, Louisiana State University, Baton Rouge, LA. 
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All subjects were weighed in indoor clothing, without shoes. The 
weights were recorded to the nearest quarter of a pound. An adjust-
ment was made for weight of clothing worn by each subject, using 
average weights of common clothing items indicated on a check list. 
The estimated weight of the clothing at weighing was subtracted from 
the total weight recorded. 
Triceps skinfold and arm circumference were measured at the same 
site on the right arm. The midpoint of the distance between the lat-
eral margin of the acromial process of the scapula to the tip of the 
olecranon was marked using a non-stretchable tape. The subject's 
right arm was relaxed and flexed at 90° at the elbow. The circum-
ference was measured at this point using the tape pulled just to fit. 
The skinfold was measured approximately 1 cm away from the midpoint 
by lifting the skin parallel to the long axis of the bone with the 
arm in a vertical position. Lange calipers were used and the measure-
ment recorded to the nearest 0.1 mm (157). 
Clinical Data 
A questionnaire, administered by a qualified nurse or physician, 
was used to obtain data on menstrual cycle, use of oral contracep-
tives, alcohol use, smoking, and medical history for the subject. 
Blood pressure was measured. 
Blood Collection 
A medical technologist drew blood samples from each subject in a 
fasting state. Two samples of 10 ml venous blood in heparin, one of 
5 ml in ethylene-diaminetetracetic acid (EDTA) and one of 10 ml 
without anticoagulant were drawn. Blood was collected in evacuated 
tubes according to standard procedures and kept cold. Serum al-
kaline phosphatase was determined on the day of collection. EDTA 
plasma and red cells from heparized blood were kept frozen until 
assayed for plasma ribonuclease and erythrocyte zinc, respectively. 
Biochemical Analysis 
Erythrocyte Zinc Concentration 
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Following separation of cells and plasma, the red cells were 
frozen in new plastic disposable tubes until assay. Zinc content of 
the cells was determined using the procedures established for use in 
the S-150 regional project. All glassware and plasticware used in 
the ashing procedures and for storage after ashing were soaked in a 
50% HCl solution for 24 hours, and rinsed three times with distilled 
water. The materials were inverted on low ash filter paper and air 
dried in a closed cabinet. Teflon or teflon-coated instruments were 
used to handle all materials. 
Between 0.47 and 0.51 g of erythrocytes, from each subject, 
weighed to the nearest .01 g, were placed into 30 ml acid-washed 
beakers; then 5.0 ml concentrated nitric acid and 2.0 ml concen-
trated sulphuric acid were added, and the beakers were covered with 
a watch glass. Blanks were included in each run and treated ex-
actly as the samples. The beakers were allowed to sit overnight 
under a fume hood. 
The next day the beakers were placed on hot plates and heated 
slowly until gas bubbles evolved. Initially the solutions darkened 
and dark brown fumes evolved. After 1.5 to 2 hours, the solutions 
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gradually cleared to a bright yellow after light brown fumes disap-
peared. As each solution reached this point, the watch glass was 
removed. The samples and blanks were left to digest for 0.5 to 1 
hour, until the nitric acid evaporated, and fumes ceased, leaving 
only the sulfuric acid solution. If the contents of a beaker 
started to brown or char, indicating excess carbon, the beaker was 
removed from the heat and allowed to cool before resuming heating. 
After the samples cleared, they were removed from the heat and 
cooled slightly. Then 0.5 ml 30% hydrogen peroxide was added; the 
solutions were returned to the hot plate, covered with watch glasses, 
and allowed to reflux. Additions of hydrogen peroxide were re-
peated approximately every 30 minutes, or when peroxide and water 
were driven off, until the solutions were as clear as water. This 
process took an additional one to two hours. Care was taken in ad-
ding peroxide to prevent boiling over. The solutions were removed 
from the hot plates and allowed to cool for three to five minutes. 
The sides of the beakers we~e washed down with 2.0 to 2.5 ml dis-
tilled water and solutions were heated gently to dissolve all resid-
ual solids. The solutions were cooled and diluted to 10 ml with 
distilled water and stored in tightly capped, acid-washed plastic 
bottles until analyzed. 
Sample solutions and blanks were compared with zinc standards 
made up in 8% sulfuric acid. Certified atomic absorption standard 
2 
zinc reference solution of 1,000 ppm was used to prepare standard 
solutions ranging from 0.1 µg zinc/ml to 2.5 µg zinc/ml. An atomic 
2Fisher Scientific Co., Pittsburg, PA. 
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absorption spectrophotometer was used for all readings with an air-
acetylene mixture, triple slot burner head, and zinc lamp. All the 
manufacturer's recommendations for zinc analysis were followed for 
the readings, utilizing the concentration mode. For each set of 
samples and blanks, two readings were obtained in random order. 
To adjust for potential contamination from original vacutainer 
tubes and plastic storage tubes, a normal saline mixture (0.9%) was 
prepared. The saline was placed in vacutainer tubes and inverted 
several times. The solution was held at room temperature for six 
hours and then transferred to the plastic storage tubes and stored 
for 48 hours prior to analysis. Zinc was not detectable. 
Zinc concentration in erythrocytes was calculated: 
Absorbance of cell ash solution X dilution (10) • weight 
Absorbance of 1 ppm standard 
of sample (g) = µg zinc/gram red blood cell. 
Plasma Ribonuclease 
Plasma was separated by centrifugation and stored, frozen, in 
glass until assayed. Plasma ribonuclease (RNase) activity was de-
termined according to the methods described by Roth (159) and Sigulem 
(107), with some modifications, using organic chemicals from a single 
4 
source. Additional precipitating reagent was used to obtain a clear 
supernatant. 
The assay mixtures contained 0.35ml of 0.024 M Tris HCl Buffer 
(TRIZMA - HCl) pH 7.8 at 37°C; the substrate, 0.2 ml RNA solution 
3Perkins Elmer 403. 
4sigma Chemical Co., St. Louis, MO. 
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(1% Type XI yeast ribonucleic acid in distilled water); and 0.05 ml 
sample. For each sample, post-incubation blanks were prepared with 
RNA added after incubation. 
All samples and blanks were prepared in duplicate and kept in 
ice water until RNA was added, at which time the tubes were placed 
in a 37° C water bath for exactly 30 minutes. The reaction was 
stopped by the addition of 1.8 ml cold acid-alcohol, lanthanum chlo-
ride (LaC13) reagent. This precipitating agent contained 1 N HCl 
in 76% ethanol with 0.5% Lac13 (159). The samples and blanks were 
centrifuged at 2°C for 30 minutes at 2800 rpm. 
The supernatant was diluted 1:10 with distilled water, and 
absorbance was read against distilled water at 260 nm. The units 
of RNase activity were defined as: 
Average absorbance of sample - average absorbance post 
incubation blanks x 1000 
30 minutes 
X 480 (dilution factor) units/minute/milliliter. 
Serum Alkaline Phosphatase 
Activity of alkaline phosphatase in serum was determined ac-
cording to the procedure of Bessey et al. (160) as modified in the 
Sigma Technical Bulletin (161), using organic chemicals from a 
. 1 5 sing e source. Analysis was completed on fresh serum. Repeated 
analyses were done when indicated in the procedures on rapidly 
frozen serum, stored for no longer than one week. The substrate 
5sigma Chemical Co., St. Louis, MO. 
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para-nitrophenyl phosphate was mixed with distilled water (40 mg in 
13.3 ml) and either used immediately or stored frozen, as recommended. 
A 0.01 M glycine buffer, pH 10.5, was prepared and stored at 0 - 5°C. 
Duplicate dilutions of E_-nitrophenol standard solution (10 µmoles/ml) 
were used for the standard curve. 
Duplicates for each subject were prepared and the following pro-
cedures were used. The assay mixture, 0.2 ml diluted substrate and 
0.2 ml glycine buffer, was vortexed and placed in 37°C water bath to 
warm. Into each tube, 0.04 ml serum was pipetted, vortexed, and the 
tube was returned to the water bath. After exactly 30 minutes, 4.0 ml 
of 0.02 N NaOH was added rapidly to each tube and the solutions were 
gently mixed. The addition of alkali stopped the reaction and devel-
oped a color which was stable for several hours, and the intensity of 
the color formed was proportional to the phosphatase activity (161). 
Duplicate blanks were prepared each time. Absorbance of test samples 
and blanks, with distilled water as a reference, was read at 410 run. 
To adjust for background absorbance due to the serum, 0.04 ml concen-
trated HCl was added to each tube to remove the nitrophenol color, 
and a second reading was obtained. Alkaline phosphatase units cor-
responding to each reading were calculated based on the calibration 
curve developed with E_-nitrophenol standard after correction for the 
blanks. The corrected alkaline phosphatase activity for each subject 
was the average value for the second readings subtracted from the 
average of the first readings and expressed as Sigma (~) units per ml. 
Statistical Analyses 
The data are presented as least squares means (LSM) with standard 
errors (SE). LSM are used with unbalanced designs which are "esti-
mates of the class or subclass arithmetic mean that would be ex-
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pected had equal numbers been obtained" (162, p. 249). Differences 
between LSM due to age, race, and menarcheal status were tested us-
ing _!-tests for the average of two days' intakes of zinc, total pro-
tein, animal protein, and energy; and for erythrocyte zinc, plasma 
ribonuclease activity, and serum alkaline phosphatase activity. 
The relationships between zinc intake and each of the other 
variables were investigated. Subjects were grouped in categories 
according to percentage of the RDA because relationships to dietary 
zinc may not be linear. Categories were: ~50% RDA (~7.5 mg); 50 to 
75% RDA (>7.5 to ~11.2); 75 to 100% RDA (?11.2 to~ 15.0); and >100% 
RDA (>15.0 ). Comparisons of %-RDA-zinc categories were made among 
LSM for total protein, animal protein, energy, erythrocyte zinc, 
plasma ribonuclease activity, and serum alkaline phosphatase sepa-
rately for pre- and post-menarcheal subjects. 
Multiple regression analyses were used to examine the relation-
ships of the proposed indices of zinc status being investigated to 
each other and to other variables that might be involved in the rela-
tionships. Detailed information on regression analysis can be found 
in Applied Regression Analysis by Draper and Smith (163), and the SAS 
handbook (162). Variables identified in the published research 
pertinent to each index were used in a stepwise regression proce-
dure, with maximum r 2 improvement, to build the "best fit" model. 
Computer analysis involved a series of internal comparisons of the 
appropriate variables and selection of what appeared to be the most 
useful set of predictors for each index (162). The model chosen as 
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the "best fit" met the following criteria: an overall F with p<0.05; 
failure of r 2 to increase by 0.025 with the inclusion of the next var-
iable; and each variable included in the model had an F with p<0.10. 
If an entered variable had p<0.05 but failed to increase r 2 by 0.025, 
the smaller, previous model was chosen. 
To investigate further the possible relationships between EZN, 
AP, RNase, and zinc intake, certain variables were "forced" in the 
model developed for each index. Stepwise regression allows variable(s) 
to be "forced" into the model, which means the forced variable(s) are 
included first in the model. They remain in the model as other vari-
ables are added, regardless of whether they are significant or not. 
Zinc intake was "forced" in the model for EZN. For AP analysis, 
RNase, zinc intake, and EZN were "forced" singly or in combination. 
For RNase prediction, EZN and zinc intake were "forced" in the model 
singly or together. 
CHAPTER IV 
RESULTS AND DISCUSSION 
Description of the Sample 
The sample consisted of 150 adolescent females who participated 
in the S-150 regional project, Nutritional Status of Adolescent Fe-
males. Obtained data included dietary, biochemical, clinical, and 
anthropometric measures related to nutritional status. Data thought 
to be related to zinc status were analyzed. Information was col-
lected on most subjects for each measure investigated. Statistical 
assessments of intakes of zinc and related dietary components, eryth-
rocyte zinc concentration, plasma ribonuclease, and serum alkaline 
phosphatase were based on the data from 138 of the adolescents. 
The menarcheal status (before or after onset of menstruation) 
and race of the subjects by age categories are shown in Table I; 
included were 105 white females and 33 black females. Ages ranged 
from 11.5 to 16.5 years. Subjects were divided into three age cate-
gories: 11.5 to 13.4 years old were in category 12; subjects 13.5 
to 15.4 years old were in category 14; and subjects 15.5 to 16.5 
years old were in category 16. 
Due to the small number or lack of subjects in certain age cate-
gories, pre- and post-menarche sub-categories were compared first 
for all data analyses. Age and race effects were then evaluated 
within menarche category. 
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TABLE I 
NUMBERS OF SUBJECTS BY AGE, RACE, AND 
MENARCHEAL STATUS 
Pre-Menarche Post-Menarche 
Age Category white black white black 
12 32 3 5 4 
14 6 0 35 20 
16 0 0 27 6 
Total 138 41 97 
Indices of Zinc Status 
Zinc Intake and Related Dietary Components 
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The average nutrient contents of foods and supplements reported 
in two 24-hour recalls for each subject were calculated using a com-
puter program. The raw data for each subject, including age in 
months, race, menarcheal status, average intakes of zinc, total pro-
tein, animal protein and energy, and erythrocyte zinc concentration, 
plasma ribonuclease activity, and serum alkaline phosphatase activity 
were included in Appendix A. The mean zinc intake of all subjects was 
10.4 .:!: 0.47 (SE), with a range of 1.6 to 34.7 mg/day. The estimated 
range of mean zinc intakes for mixed diets consumed by Americans was 
10 to 15 mg/day (6, 61). Of the three subjects with zinc intakes of 
32 mg/day or more, two consumed zinc supplements averaging 15 mg and 
24 mg/day, and one subject reported an average intake of 4131 kcal. 
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Twenty other subjects reported intakes of 15 to 24 mg zinc, without 
supplements. Their mean zinc intake was 18.5 + 0.4 and an average 
energy intake of 2420 + 45. Thirteen subjects reported intakes of 
less than 5.0 mg zinc/day. Their mean intakes were 3.7 + 0.3 mg 
zinc, and 1032 ± 24 kcal/day. While the mean zinc intake was within 
the usual range for subjects on self-selected diets, the extremes 
of intake showed wide variation in zinc and energy intakes in this 
group of adolescents. 
The least squares mean (LSM) intakes of zinc, total protein, 
animal protein, and energy were compared for pre- and post-menarcheal 
subjects. The intakes of these dietary components were significantly 
higher in pre-menarcheal subjects than in post-menarcheal subjects 
(Table II). There was no interaction of age and race within menar-
che categories for these dietary components. No differences in 
LSM for these dietary components within menarche categories were 
found, except that the LSM energy intake of white post-menarcheal 
subjects was lower than the LSM energy intake of black post-
menarcheal subjects. 
The RDA for energy for 11-14 year old females is 2200 kcal and 
for 15-18 year old females is 2100 kcal/day (61). For this study, 
the average value of 2150 kcal was used to represent the RDA for 
energy, since subjects were in both age ranges. The RDA for zinc 
(15 mg/day) and protein (46 g/day) are the same for girls 11 to 18 
years old. Based on the RDA, the LSM for pre-menarcheal subjects 
were 81% for zinc, 166% for protein, and 100% of the average RDA for 
energy. The LSM for post-menarcheal subjects were 64% for zinc, 
128% for protein, and 80% of the average RDA for energy. 
Group 
Menarcheal Status 
Pre-menarche 
Post-menarche 
Pre-menarche 
~ 
12 
14 
Race 
white 
black 
Post-menarche 
Age 
12 
14 
16 
Race 
white 
black 
TABLE II 
LEAST SQUARES MEAN INTAKES OF ZINC, TOTAL PROTEIN, 
ANIMAL PROTEIN, AND ENERGY BY MENARCHEAL STATUS, 
AND BY AGE AND RACE, ACCORDING TO MENARCHE 
Zinc 
(mg) 
12.2 + o.8*a** 
9.6· + 0.6b 
11.4 + 2.0 
9.4 + 3.3 
11.7+1.4 
9.2 + 4.0 
11. 5 + 1. 7 
9.6 + 0. 7 
9.5 + 0.9 
9.8 + 0.8 
10.5+1.0 
Protein 
(g) 
76 + 3a 
59 + 2b 
78 + 10 
73 + 16 
74 + 7 
77 + 20 
60 + 6 
60 + 3 
58 + 3 
58 + 3 
62 + 4 
Animal Protein 
(g) 
54 + 3a 
40 + 2b 
52 + 7 
51 + 13 
54 + 6 
49 + 15 
39 + 5 
41 + 2 
39 + 3 
39 + 2 
41 + 3 
*Least Squares Mean ± Standard Error. 
Energy 
(kcal) 
2158 + 95a 
1728 + 62b 
2312 + 225 
2204 + 378 
2095 + 166 
2421 + 460 
1724 + 179 
1798 + 74 
1790 + 101 
1612 + 82a 
1929 + 107b 
**LSM in a column not sharing a common superscript letter within menarche categories are different p<0.05, 
t-test. If no superscript is given, no differences within menarche categories were found. 
.!:'" 
o::> 
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The RDA are set as a goal for planning recommended levels of 
daily nutrient intakes intended to cover the needs of almost all 
healthy individuals (61). The RDA for adolescents are based on 
chronological age; however, nutrient requirements are more closely 
related to physiological age, since they are affected by growth and 
maturation and the resulting changes in body composition (12). Nu-
trient needs during adolescence are greatest during pubescence 
(period of sexual development ending with the capacity for reproduc-
tion), usually occurring between 10 and 13 years of age in females. 
After this period~ growth is slower and nutrient needs gradually de-
crease to adult levels by the end of adolescence. Due to diffi-
culties in assessing physiological age in adolescents and estimating 
nutrient requirements on this basis, recommendations are based on 
chronological age (12). Overall, the intakes of selected nutrients 
of pre-menarcheal subjects in the S-150 study was greater than the 
intakes of post-menarcheal subjects, which may reflect increased 
food intake in younger girls to meet the demands for growth. The 
intakes of the nutrients other than total energy, however, were not 
affected by age or race, within menarche categories, indicating 
menarcheal status was the major factor influencing intakes among 
those investigated. 
The relationships between zinc intake and the other dietary 
components (protein, animal protein, and energy) were investigated 
by grouping all subjects according to percentage of the RDA for 
zinc (%-RDA-zinc). The %-RDA-zinc categories were: less than or 
equal to 50% RDA (27.5 mg); 50 to 75% RDA(>7.5 to 211.2); 75 to 100% 
RDA (>11.2 to 215.0); and greater than 100% RDA (>15.0). As there 
were differences in intakes of total protein, animal protein, and 
energy (see Table II) between pre- and post-menarcheal subjects, 
the LSM for these dietary factors were compared among %-RDA-zinc 
categories only within each menarche category (Table III). 
%-RDA-zinc 
TABLE III 
LEAST SQUARES MEAN INTAKES OF TOTAL PROTEIN, 
ANIMAL PROTEIN, AND ENERGY BY %-RDA-ZINC, 
ACCORDING TO MENARCHE 
Total Protein 
N (g) 
Animal Protein 
(g) 
Pre-menarche 
Energy 
(kcal) 
50 
<50 
50-75 
75-100 
>100 
10 50 + 8*a** 
9 67 + 8a,b 
12 82 + 7b 
10 111 + 9c 
35 + 6a 
47 + 6a,b 
59 + 5b 
86 + 6c 
1660 + 228a 
1897 + 212a,b 
2321 + 204b 
2817 + 244b,c 
Post-menarche 
<50 
50-75 
75-100 
>100 
*LSM + SE. 
37 
30 
19 
11 
43 + 2a 
61 + 3b 
72 + 3c 
80 + 4c 
28 + 2a 
40 + 2b 
48 + 3C 
57 + 3d 
1321 + 34a 
1772 + 92b 
2069 + 108c 
2165 + 140c 
**LSM in a column not sharing a common superscript letter are dif-
ferent within menarche categories, at p<0.05, t-test. 
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As shown in Table III, the intakes of total protein, animal pro-
tein, and energy increased with increased zinc intakes. The associ-
ation between dietary zinc, total protein, and energy had previously 
been reported (59, 63, 64). Different sources of protein, however, 
altered zinc content in metabolic diets (63); zinc content was higher 
in diets including beef and liverwurst than in diets containing tur-
key or ham. The diets of the pre- and post-menarcheal subjects with 
<50% RDA for zinc probably supplied adequate total protein (91 to 98% 
RDA), but low energy intakes (61 to 77% average RDA). Diets with 75 
to 100% of the RDA for zinc contained adequate total protein (158 to 
177% RDA) and close to the recommended intake of energy (96 to 108% 
RDA). The difference in zinc intake probably reflected different 
choices of animal protein. 
Recent reports indicated that one-third or more of the adoles-
cents studied consumed less than two-thirds of the RDA for zinc 
(10 mg/day). Fifty-five percent of the subjects in the S-150 study 
consumed less than two-thirds of the RDA for zinc, compared to 37% 
reported by Greger et al. (13) and 33% reported by White (62). In 
a balance study with 14 adolescent females (mean age 13.2 + 0.6), 
40% of the subjects were in negative zinc balance on 13.4 mg zinc/day 
(89% RDA) and 64% were in negative zinc balance on 7.4 mg/zinc/day 
(49% RDA), on diets containing mixed foods (59). Although zinc in-
take cannot be used by itself to indicate deficiency states, these 
studies reported a large number of subjects below the estimated 
usual U.S. adult zinc intake of 10-15 mg/day. Understanding the 
relationship between zinc intake and measures of zinc status is es-
sential to interpret these low intakes. 
Table IV showed the mean zinc, protein, and energy intake and 
zinc-to-energy ratio for the S-150 subjects compared to values re-
ported by others for adolescents consuming self-selected diets. 
Subjects reported by Greger et al. (13) were 12.8 ± 0.8 year old 
females, with menarche experienced by 39%. Subjects in White's 
study (62) were 14 to 16 years old. No information on menarcheal 
status was given. In the S-150 project, ages ranged from 11.5 to 
16.5 years and 29% were pre-menarcheal. The zinc-to-energy ratio 
equivalent to the RDA for adolescent females would be 7.0 mg/1000 
kcal (61). The adolescent females in the S-150 project consumed 
5. 5 mg zinc/1000 kcal. The analyzed composites of one day self-
selected diets of 15 adolescents (62) contained a higher zinc-to-
energy ratio (8.8/1000) than the self-selected diets in Greger's 
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et al. (13) and in the S-150 study. No information was available to 
explain the higher zinc-to-kcal ratio in White's study (62). Ana-
lyzed metabolic diets contained zinc-to-energy ratios of 5.5/1000 
(60) and 6.6/100 (63), indicating the zinc content of self-reported 
diets was similar to the zinc content of analyzed diets. 
Several dietary substances reported to interfere with zinc ab-
sorption have been fiber, phytic acid, and combinations of calcium 
and phytic acid. The mean crude fiber content of the diets of the 
subjects in this study was 2.5 g/day. This level was below the re-
ported crude fiber intake of 7.8 g/day adversely affecting zinc 
status in 12 non-vegetarian females (SO), and below the level caus-
ing negative zinc balance reported in two adult subjects on analyzed 
diets with 30 g dietary fiber/day (mostly in the form of whole meal 
bread) and 19 mg zinc (164). The mean calcium intake in subjects in 
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the S-150 project was 822 ± 32 mg/day. L'ow or high calcium intakes 
did not affect zinc absorption (23, 58), but combinations of 
calcium-phytic acid had a negative effect on zinc absorption (59). 
The phytic acid content of the diets of subjects in the S-150 proj-
ect was not evaluated. 
Group N 
S-150 138 
Greger 183 
et al. 
1979 (13) 
White 15 
1969 (62) 
*Mean + SD. 
-
**Calculated 
TABLE IV 
COMPARISON OF MEAN DIETARY ZINC, PROTEIN, 
AND ENERGY FROM SELECTED STUDIES 
Zinc Protein Energy 
(mg/day) (g/day) (kcal) 
10.4 + 5.4* 64 + 2 1856 + 54 
11. 3 + 4. 7 76 + 2 2030 + 587 
12.0 + 5.0** 55 + 16 1501 + 425 
from mean data given by authors. 
Zinc:Energy 
mg:lOOO kcal 
5.5 
5.6~'<* 
8.6 
Multiple regression was used to calculate the "best" fitting 
model to predict (or account for) the variation in dietary zinc. 
The factors included: animal protein, protein, copper, energy, cal-
cium, magnesium, and fiber intakes. The stepwise regression proce-
dure for all subjects resulted in the following equation: 
dietary zinc= -2.289 + 0.163 total protein (g) + 1.570 
copper (mg). 
The equation accounted for 71% of the variability in dietary zinc. 
Probabilities for each variable and the model were <0.0001. De-
scriptions of all other models with up to seven variables were in-
eluded in Appendix B. 
Erythrocyte Zinc Concentration 
The mean erythrocyte zinc concentration (EZN) for 138 subjects 
was 7.6 + 0.15 µg/g red cells, with a range from 3.7 to 13.3 µg/g. 
There was no interaction between race and age, in either menarche 
category, for EZN. There was a difference in EZN between pre- and 
post-menarcheal subjects (Table V). Pre-menarcheal subjects had a 
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lower LSM for EZN than post-menarcheal subjects. In addition, there 
were significant differences due to age among post-menarcheal sub-
jects. The younger post-menarcheal subjects had lower EZN than older 
post-menarcheal subjects. 
The group with the lowest EZN was the post-menarcheal subjects 
in age category 12. The fact that these adolescents had menstru-
ated indicated at least a minimal degree of adequacy of zinc nutri-
ture prior to menarche. These girls had presumably just experienced 
the time of most rapid adolescent growth. 
The zinc intake of adolescent females in this study decreased 
with age (see Table III), while the EZN increased with age (Table V). 
No differences were found in LSM for EZN among %-RDA-zinc categories, 
either before or after menarche (Table VI). 
These results suggested that dietary zinc was not a good predic-
tor of EZN among these adolescent females, except possibly within a 
TABLE V 
LEAST SQUARES MEAN OF ERYTHROCYTE ZINC CON-
CENTRATION BY MENARCHEAL STATUS, AND 
Group 
Menarcheal Status 
Pre-menarche 
Post-menarche 
Pre-menarcheal 
Age 
12 
14 
Race 
white 
black 
Pos t-menarcheal 
Age 
12 
14 
16 
Race 
white 
black 
*LSH + SE. 
BY AGE AND RACE, ACCORDING 
TO MENARCHE 
Erythrocyte Zinc 
(µg/g) 
6.8 + 0.3*a** 
7.9 + o.2b 
6.9 + o.s 
6.5 + 0.8 
6.6 + 0.3 
6.8 + 0.9 
5.9 + 0.6a 
b 7.6 + 0.2 
8.7 + 0.3c 
7.5 + 0.3 
7.3 + 0.3 
**LSM not sharing a common superscript letter within menarche 
categories are different p<0.05, t-test. If no super-
script is given, no differences within menarche categories 
were found. 
SS 
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narrower age span. Stepwise regression analysis for all subjects in-
eluded the following variables: serum protein, hemoglobin, height, 
skinfold, arm muscle mass, race, menarcheal status, and per capita 
income; and intakes of total protein, zinc, and energy. The follow-
ing equation accounted for 20% of the variability in EZN in this 
study: 
EZN = 0.0541 + 0.0447 age (months). 
Probabilities for the variable and the model were below 0.0001. De-
scriptions of other models, including up to 10 variables, were in-
eluded in Appendix C. 
TABLE VI 
LEAST SQUARES MEAN ERYTHROCYTE ZINC BY 
%-RDA-ZINC, ACCORDING TO MENARCHE 
%-RDA-Zinc 
Pre-Menarche 
~50 
50-75 
75-100 
>100 
Post-Menarche. 
Erythrocyte Zinc 
(µg/g) 
6.3 + 0.6* 
6.9 + 0.5 
6.7 + 0.5 
6.6 + 0.6 
<50 7.8 + 0.3 
50-75 7.1 + 0.3 
75-100 7.4 + 0.4 
>100 7.5 + 0.5 
. *LSM + SE. No differences within menarche categories 
were found. 
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No values for EZN in adolescents have been reported in the lit-
erature. Values reported for adults were expressed in µg/ml. If 
one milliliter of packed red cells were equivalent to 1.1 g red cell 
concentrate (165), the range of values from 10 to 14 µg/ml reported 
for adults (80, 87-90) would be equivalent to about 9 to 13 µg/g. 
The range of EZN values for subjects in this study was 3.7 to 13.3 
µg/g erythrocytes. The mean EZN (8.7 ±. 0.3 µg/g) for older post-
menarcheal subjects corresponded to the lower end of the range of 
adult values; other groups had slightly lower mean values. 
The metabolism of EZN has not been fully investigated. Pub-
lished research (in vitro studies) reported zinc efflux from 
erythrocytes pre-loaded with high or low levels of zinc was small 
and independent of the pre-efflux zinc concentration (94); thus, 
once zinc was associated with erythrocytes it tended to remain. 
The applicability of in vitro studies on EZN metabolism to in vivo 
zinc metabolism has not been investigated. In addition, the influ-
ences of growth and hormonal changes that occur during adolescence 
on zinc metabolism in general, and in erythrocytes specifically, 
have not been studied. The use of EZN in assessing zinc status 
needs further investigation. 
Plasma Ribonuclease 
The plasma ribunuclease activity (RNase) has not previously 
been reported in healthy adolescents. The mean RNase activity for 
138 subjects was 4.9 ±. 0.06 units/min/ml, with a range of 3.5 to 
7.5 units/min/ml. There was no interaction between race and age, 
in either menarche category for RNase. The LSM for RNase for 
pre-menarcheal subjects was greater than the LSM for RNase for 
post-menarcheal subjects (Table VII). There were no differences in 
LSM RNase activity among %-RDA-zinc categories, either before or 
after menarche (Table VIII). 
TABLE VII 
LEAST SQUARES MEAN PLASMA RIBONUCLEASE BY 
MENARCHEAL STATUS, AND BY AGE AND 
RACE, ACCORDING TO MENARCHE 
Group 
Menarcheal Status 
Pre-menarche 
Post-menarche 
Pre-menarche 
Age 
12 
14 
Race 
white 
black 
Post-menarche 
Age 
12 
14 
16 
Race 
white 
black 
*LSM + SE • 
Plasma Ribonuclease 
(uni ts/min/ml) 
5.2 + 0.2*a** 
4.9 + o.1b 
5.4 + 0.4 
5.0 + 0.4 
5.0 + 0.2 
5.4 + 0.4 
5.1 + 0.2 
4.8 + 0.1 
4.8 + 0.1 
5.0 + 0.1 
4.8 + 0.1 
**LSM not sharing a common superscript letter within 
menarche categories are different at p<0.05, t-tests. 
If no superscript letter is given, no differ~ces 
within menarche categories were found. 
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TABLE VIII 
LEAST SQUARES MEAN PLASMA RIBONUCLEASE BY 
%-RDA-ZINC, ACCORDING TO MENARCHE 
%-RDA-Zinc 
Pre-menarche 
<50 
50-75 
75-100 
>100 
Post-menarche 
Plasma Ribonuclease 
(units/min/ml) 
5 • 2 ± 0 • )ic' *ic 
4.9 + 0.3 
5.0 + 0.3 
5.0 + 0.3 
s')O 5.0 + 0.1 
50-75 4.9 + 0.1 
75-100 5.0 + 0.2 
>100 4.7 + 0.2 
*LSM + SE. No differences within menarche categories 
were found. 
59 
Stepwise regression analysis accounted for only a small portion 
2 
of the variability in RNase activity in this study (r =.06). The 
"best fit" model had the following equation: 
RNase = 6.9096 - 0.0052 protein (g) - 0.0097 age (months). 
The variables included all at once in the procedure were: serum 
protein, EZN, hemoglobin, height, skinfold, arm muscle mass; and 
intakes of protein, zinc, and energy; and age, menarcheal status, 
race, and per capita income. Probabilities for all variables were 
below 0.0577, and for the model, 0.0196. Descriptions of other mod-
els, with up to 10 variables, were included in Appendix D. 
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The plasma RNase activity for normal, healthy adults was 3.1 
+ 0.01 (SE) units/min/ml (91). The RNase values of four adult males 
ranged from 3.7 to 4.1 units/min/ml (82). Values reported by au-
thors using a similar procedure to that in this study were: for 
infants less than 10 days old, 12.1 + 2.5 (SD) units/min/ml; for 
20 day old infants, 5.8 ± 1.1; and for adults, 29 to 27 years old, 
5.7 ± 0.7 (107). The mean RNase activity, 4.9 ± 0.06 units/min/ml, 
for adolescent females in this study was lower than the value for 
adults in the study using similar procedures (107). 
Since menarcheal status influenced RNase values, the range of 
values for pre- and post-menarcheal subjects needs further investi-
gation. Establishment of normal values is necessary prior to using 
RNase as an indicator of zinc status. 
Serum Alkaline Phosphatase 
Values for serum alkaline phosphatase activity (AP) ranged from 
1.0 to 9.2 Sigma (E) units/ml, with a mean of 3.7 + 0.16 E units/ml. 
The pre-menarcheal subjects had significantly greater LSM for AP 
activity than post-menarcheal subjects (Table IX). There was no in-
teraction between age and race, in either menarche category. The 
younger post-menarcheal subjects (age categories 12 and 14) had 
greater LSM for AP than the older post-menarcheal subjects (age cate-
gory 16). There was no difference due to race within menarche cate-
gories. Serum AP had been shown to peak between 10 and 13 years of 
age and then gradually declined to adult values by the eighteenth 
year in females (121-126). The data for the S-150 adolescents are 
consistent with these reports. 
TABLE IX 
LEAST SQUARES MEAN SERUM ALKALINE PHOSPHATASE 
BY MENARCHEAL STATUS, AND BY AGE AND RACE, 
ACCORDING TO MENARCHE 
Group 
Menarcheal Status 
Pre-menarche 
Post-menarche 
Pre-menarche 
Age 
12 
14 
Race 
white 
black 
Post-menarche 
Age 
12 
14 
16 
Race 
white 
black 
*LSM + SE. 
Alkaline Phosphatase 
(l:; units/ml) 
5.8 + 0.2*a** 
2.8 + o.1b 
5.5 + 0.5 
5.0 + 0.9 
5.6 + 0.4 
4.9 + 1.0 
3.7 + 0.4a 
3.0 + o.2a 
- b 2.1 + 0.2 
3.0 + 0.2 
2.9 + 0.2 
**LSM not sharing a common superscript letter within 
menarche categories are different, p<0.05, t-test. 
If no superscript letter is given, no differences 
within menarche categories were found. 
A scattergram of AP values and months past menarche indicated 
AP values decreased as months past menarche increased (Figure 1). 
Regression analysis showed AP decreased by -0.045 units per month 
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Figure 1. Scattergram of Serum Alkaline Phosphatase and Months Past Menarche 
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(p<0.001). This corresponds with the age category 16 having a 
lower LSM for AP than subjects in age categories 12 and 14. 
The LSM for AP among post-menarcheal subjects in <SO and SO 
to 7S%-RDA zinc categories were lower than the LSM for AP for sub-
jects in >100%-RDA-zinc category (Table X). There were no differ-
ences in LSM for AP among %-RDA-zinc categories for pre-menarcheal 
subjects. 
TABLE X 
LEAST SQUARES MEAN SERUM ALKALINE PHOS-
PHATASE BY %-RDA-ZINC, ACCORDING 
%-RDA-Zinc 
Pre-Menarche 
<SO 
S0-7S 
7S-100 
>100 
Post-Menarche 
<SO 
S0-7S 
7S-100 
>100 
*LSM + SE. 
TO MENARCHE 
Alkaline Phosphatase 
(Z unts/ml) 
S.7 + 0.6 
s.s + 0.6 
S.7 + 0.6 
S.3 + 0.7 
2.7 + 0.2a 
2.8 + o.2a 
3.1 + 0.3a,b 
3.8 + 0.3b 
**LSM not sharing a common superscript letter within 
menarche categories are different, p<0.05, !_-test. 
If no superscript letter is given, no differences 
within menarche categories were found. 
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Table XI shows the comparison of AP values to other studies 
with subjects of similar ages. The age groups differed among the 
studies so groups were combined to yield age categories similar to 
the S-150 categories. Since the studies expressed AP values in dif-
ferent units, the reported units were combined and converted to 
Sigma units, using standard conversion value (115). Although the 
results are not directly comparable, the values for the S-150 project 
seemed consistent with the other studies. 
Multiple regression analysis was used to identify those vari-
ables that would be the best predictors of AP. The variables, 
analyzed all together, included: EZN, RNase and serum protein; in-
takes of energy, vitamin D, calcium, and zinc; height, skinfold, arm 
muscle mass, age, race, menarcheal status, and per capita income. 
The model produced this equation: 
AP= 9.051 - 0.3999 RNase (units/min/ml) + 0.0018 vitamin D 
(IU) - 0.0381 age (months) + 1.9551 menarcheal status 
(1 = post; 2 = pre). 
Sixty-one percent of the variability in AP was accounted for by this 
model, with all variables p<0.0059, and the full model p<0.0001. 
Descriptions on all models, up to 10 variables, were in Appendix E. 
Relationships Among Zinc Intake, Ery-
throcyte Zinc Concentration, Plasma 
Ribonuclease Activity, and Sertnn Alka-
line Phosphatase Activity 
The relationships of zinc intake to the biochemical indices of 
zinc status and to each other were further investigated. There were 
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no differences in LSM for EZN (see Table VI) or in LSM for RNase 
(see Table VIII) among %-RDA-zinc categories for either pre- or post-
menarcheal groups. The LSM for AP of post-menarcheal subjects showed 
the LSM for >100 %-RDA-zinc category was greater than for all other 
groups (see Table X). A scattergram of AP values by zinc intake in-
dicates four subjects had AP values greater than 5.0, but only two 
of those had zinc intakes over 15 mg/day (Figure 2). 
TABLE XI 
COMPARISON OF MEAN SERUM ALKALINE PHOS-
PHATASE VALUES WITH SELECTED STUDIES 
Group 
S-150* 
Round, 1973 
(121)** 
Harrison et al. 
1948 (123) ~~ 
Clark et al. 
1950 (124)** 
Bennett et al. 
1976 (125)*** 
Age Categories 
11.5 - 12.9 
13.0 - 14.9 
15.0 - 16.5 
10 - 12 
13 - 14 
15 - 16 
10 - 12 
13 - 14 
15 - 16 
10 - 12 
12 - 14 
14 - 16 
10 - 12 
13 - 14 
15 - 16 
*Value originally expressed as Sigma units. 
**Value converted from King-Armstrong units. 
***Value converted from International units. 
Alkaline Phosphatase 
O:: units/ml) 
5.43 
3.27 
2.19 
3.62 
2.47 
1. 42 
6.97 
5.15 
1. 90 
5.98 
4.79 
3.38 
5.66 
3.89 
2.07 
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Scattergrams for EZN and zinc intake, AI! and zinc intake, RNase 
and zinc intake, AI! and RNase, AI! and EZN, and RNase and EZN, by 
menarcheal status, showed no relationships between the variables 
(Figures 3-13, Appendix F), though ~ase did appear in the best equa-
tion to predict AJ!. When subjects were categorized according to EZN 
groups (<6.5, 6.5 to 8.9 or >8.9 µg/g), no differences in RNase or 
AI!, in either menarche category, were found (Table XII). 
Variable 
TABLE XII 
LEAST SQUARES MEAN FOR INDICES OF ZINC 
STATUS BY ERYTHROCYTE ZINC, ACCORD-
ING TO MENARCHE 
Menarcheal Erythryocyte Zinc 
Status <6.5 6.5 - 8.9 
Plasma Ribonuclease Pre 5.2 + 0.2* 5.2 + 0.2 
Post 5.0 + 0.2 4.9 + 0.1 
Serum Alkaline Phos- Pre 5.3 + 0.4 5.9 + 0.4 
phatase Post 3.1 + 0.3 2.7 + 0.2 
(µg/ g) 
>8.9 
4.6 + 0.5 
4.7 + 0.1 
7.0+1.0 
2. 7 + 0.3 
*LSM + SE. No differences within menarche categories were found. 
In marginal zinc deficiency, low AI! activity, low EZN, and low 
zinc intake with high RNase activity were found in a metabolic study 
with four adult males consuming a semi-purified diet containing 2.7 
or 3.5 mg zinc/day (82). Therefore, additional regression analysis 
was performed on the S-150 data to determine the effect(s) of 
"forcing" one or more of these variables into the models already 
developed. The results of these procedures suggested certain re-
lationships between variables (zinc intake and EZN; and AP and EZN) 
when only "forced" variables were in the model; however, when the 
single or best two variable models were presented with a free 
choice variable, the "forced" variable's probability increased be-
yond the criteria established in this study (Table XIII). 
Variable for 
the Model 
EZN 
RNase 
*Model with 
TABLE XIII 
MULTIPLE REGRESSION ANALYSES FOR SELECTED 
MODELS WITH "FORCED" VARIABLES 
Included Variable* 2 /2nd Entered** S-Value r 
Zinc intake* -0.0478 .02 
Zinc intake** -0. 0172 .19 
Age (months) 0.0436 
EZN* -0.2596 .06 
EZN** -0.0528 .49 
Menarchal status 2.8599 
EZN* -0.0485 .01 
EZN** -0.0203 .03 
Age -0.0067 
one "forced" variable. 
**Best two variable modei (with one "forced"). 
Prob>F 
0.0879 
0.5094 
0.0001 
0.0041 
0.4417 
0.0001 
0.1769 
0.6057 
0.1012 
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Additional information on the models in Table XIII were in-
cluded in Appendix G, with up to five variables. Also in Appendix 
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G are the variable models with two or three "forced" variables. 
These additional regression analyses indicated for this study that 
the variables menarcheal status and age predicted zinc intake, AP, 
EZN, and RNase better than these indices predicted each other. Ap-
parent relationships among these indices may have resulted from com-
mon associations with other variables. 
Summary and Recommendations 
Wide ranges in values for zinc intakes, EZN, RNase, and AP were 
found in the adolescent females studied. Menarcheal status was an 
important factor in identifying differences in these indices among 
the subjects. There were no differences due to race. Age, menar-
cheal status, and RNase explained 61% of the variation in AP. Total 
protein and copper intakes explained 71% of the variation in zinc 
intakes. Age alone and age plus total protein intake, respectively, ac-
counted for only a small portion of the variations in EZN (20%) and 
RNase (6%). 
The biochemical determinations of EZN, RNase, and AP were feas-
ible within the limitations of this survey. The amount of sample 
required for AP (0.04 ml serum) and RNase (0.05 ml EDTA plasma) 
analyses was small, while the determination of EZN required a greater 
amount of sample (0.50 g erythrocytes). The need to collect samples 
in three different media required changing vaccutainer tubes during 
blood collection. Thus problems of drawing blood from subjects, of 
providing adequate refrigeration of all samples, and of separation 
of the blood are encountered in surveys. 
Although the procedures for determination of AP were easily 
handled, this enzyme is affected by factors other than zinc. These 
other factors limit the use of AP as a sole indicator of zinc sta-
tus. The abrupt change in activity after menarche in females, the 
relationship of AP to bone metabolism, and the relationship of AP 
to protein status, must be evaluated prior to its use as an index 
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of zinc status. The determination of AP activity prior to and after 
supplementation with zinc has been proposed as a useful measure of 
zinc status (6). This procedure, however, would have limited ap-
plication in a survey. 
The determination of plasma RNase activity was more difficult 
than the determination of AP. In order to obtain a clear super-
natant, it was necessary to add additional precipitating -reagent, to 
keep the assay mixture on ice prior to and after incubation, to use 
covered tubes during centrifugation, and to have exact timing. In 
addition, special cuvettes were needed as the absorbance was read 
at 260 nm. Further standardization of the assay method for RNase 
is necessary to develop routine procedures. As RNase activity was 
affected by protein status in animals (104) and in humans (106), its 
use as a sole indicator of zinc status may be limited. 
EZN has been proposed as an indicator of long-term zinc status 
(7). The factors that influence the metabolism of EZN and zinc up-
take by erythrocytes are not fully understood. In addition, the 
impact of the physiological changes associated with growth and ma-
turation during adolescence on erythrocyte zinc has not been 
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established. The normal range of values for EZN for different stages 
of maturity should be determined prior to using EZN as an index of 
zinc status in adolescents. 
Even when known influences such as menarche and age are ac-
counted for, as in this study, relationships among zinc intake, EZN, 
RNase, and AP are not clear. Other proposed indices of zinc status 
such as plasma zinc concentrations and carbonic anhydrase activity, 
are not readily applicable for survey work. Preventing contamina-
tion of plasma zinc from hemolysis or collection materials in a sur-
vey situation are required for plasma zinc concentrations to be a 
useful index of zinc status. Streamlining the routine analysis of 
carbonic anhydrase activity with readily available equipment is 
necessary prior to its use in surveys as an index of zinc status. 
With advances in research in these areas, the relationships among 
various currently used or proposed indices of zinc status may help 
identify the most reliable predictors of zinc status. 
Further research is needed in a number of areas. The researcher 
recommends: 
1. Investigation of the effects of physiological changes dur-
ing growth and maturation on EZN, RNase, and AP to establish normal 
range of values for different stages of physiological maturity: 
2. Improved accuracy and reliability in collecting information 
on zinc intakes; 
3. Investigation of the factors that may influence the metab-
olism of EZN to determine its sensitivity as an indicator of zinc 
status; 
4. Simplification of methods of determining EZN, carbonic anhy-
drase activity and plasma zinc concentrations in survey work; and 
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5. Determination of the relationships among EZN, AP, RNase, and 
AP and other proposed indices of zinc status, such as plasma zinc 
and carbonic anhydrase activity, to determine the best combinations 
of predictors of zinc status in adolescent females. 
CHAPTER V 
SUMMARY 
Limited information on the zinc status of adolescent females 
was available. The importance of adequate zinc, especially during 
periods of growth, has been well established. There was, however, 
no standardized procedure for assessing zinc status in humans. Re-
cent reports have suggested erythrocyte zinc concentration (EZN), 
serum alkaline phosphatase activity (AP), and plasma ribonuclease 
activity (RNase) may be useful indicators of zinc status and have 
applicability to survey work. 
In this study, the range of values and the relationships of 
EZN, RNase, and AP to each other and to zinc intake were investi-
gated in a group of 138 adolescent females. These subjects were 
part of a larger group who participated in the S-150 regional proj-
ect, Nutritional Status of Adolescent Females. Dietary, anthropo-
metric, clinical, and biochemical data were collected. Information 
on intakes of zinc, total protein, animal protein, and energy were 
obtained from two 24-hour recalls and mean nutrient contents of food 
and supplements were calculated. Intakes of zinc, total protein, 
animal protein, energy and EZN, RNase, and AP were compared by age, 
race, menarcheal status, and %-RDA-zinc categories. Categories 
used for %-RDA-zinc were: ::_50% RDA; 50 to 75% RDA; 75 to 100% RDA; 
and > 100% RDA. 
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Blood samples were drawn in a fasting state and analyzed for 
three indices suggested to reflect zinc status. EZN was measured 
by atomic absorption spectrophotometry following a wet ash proce-
dure. Plasma RNase and serum AP activities were determined by 
spectrophometric assays. 
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Effects of menarcheal status, age, and race were evaluated by 
analysis of variance. Multiple regression analysis was then used to 
determine the "best fitting" model for each index from a given list 
of related factors. Additional stepwise regression analysis "forced" 
into the models a variable that was expected to have an effect, 
whether or not the criterion for inclusion was met. 
The LSM intake of zinc for post-menarcheal subjects (9.6 ± 0.55 
mg, range 1.6 to 33.4 mg) was less than the LSM intake of zinc for 
pre-menarcheal subjects (12.2 + 0.85 mg, range 3.0 to 34.7 mg). In-
takes of zinc, total protein, animal protein, and energy were higher 
for pre-menarcheal subjects than for post-menarcheal subjects. The 
intakes of total protein, animal protein, and energy increased with 
increased zinc intakes. 
The LSM for EZN in pre-menarcheal subjects (7.9 ± 0.18, range 
3.7 to 11.0 µg/g erythrocyte) was lower than the LSM for EZN in post-
menarcheal subjects (6.8 ± 0.27, range 4.0 to 13.3 µg/g). Within the 
post-menarcheal group, the younger subjects had lower LSM for EZN 
than the older subjects. There were no differences in LSM for EZN 
among %-RDA-zinc categories, either for pre- or post-menarcheal 
subjects. 
The LSM for RNase of pre-menarcheal subjects (5.2 ± 0.12, range 
3.6 to 7.5 units/min/ml) was greater than the LSM for RNase in 
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post-menarcheal subjects (4.9 ::!:. 0.07, range 3.5 to 7.5 units/min/ml). 
There were no differences in LSM for RNase among %-RDA-zinc cate-
gories in either pre- or post-menarche categories. 
Pre-menarcheal subjects had a greater LSM for AP (5.8 ::!:. 0.21, 
range 2.3 to 9.2 L units/ml) than LSM for AP for post-menarcheal 
subjects (2.8 ::!:. 0.14, range 1.01 to 8.9 L units/ml). Within the 
post-menarcheal group, there was an age-related difference in LSM 
for AP with younger subjects having greater LSM for AP than older 
subjects. 
Multiple regression analysis resulted in equations accounting 
for 71% variability in zinc intake; 20% for EZN; 6% for RNase; and 
61% for AP. The variable age appeared in all models, except for 
zinc intake, as it was not included in the list. 
Zinc intakes were not related to EZN, AP, or RNase, except for 
AP in post-menarcheal subjects. In addition, no clear relationships 
were detected between AP and RNase; AP and EZN; or RNase or EZN. 
When these indices were "forced" into equations, the resulting rela-
tionships lost significance as other variables were freely added to 
the models. The major factors influencing the suggested indices of 
zinc status in this study were menarcheal status and age. 
The biochemical determinations of EZN, RNase, and AP were pos-
sible within the limitations of this survey. As factors other than 
dietary zinc influenced each of them, their general use as sole 
indicators of zinc status cannot be recommended. 
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APPENDIX A 
LIST OF ABBREVIATIONS IN COMPUTER PRINTOUTS 
AND COMPUTER LISTS OF RAW DATA 
BY MENARCHEAL STATUS 
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Age 
AP 
An pro 
Ca 
Cu 
E 
EZN 
Fib 
Mg 
Mens 
HB 
Muse 
Peine 
Pro 
Race 
RNase 
Rht 
Skfd 
Spro 
Two yr 
VD 
ZN 
91 
List of Abbreviations in Computer Printouts 
- Age (months) 
- Serum alkaline phosphatase (L units/ml) 
- Animal protein intake (g) 
- Calcium. intake (mg) 
- Copper intake (mg) 
- Energy intake (kcal) 
- Erythrocyte zinc concentration (µg/g) 
- Crude fiber intake (g) 
- Magnesium intake (mg) 
- Menarcheal status (l=post, 2~pre) 
- Hemoglobin (mg/dl) 
- Arm muscle mass (squared centimeters) 
- Per capita income 
- Total protein intake (g) 
- Race (l=white, 2=black) 
- Plasma ribonuclease activity (units/min/ml) 
- Height (relative to U.S. heights for age) 
- Skinfold (millimeters) 
- Serum protein (g/dl) 
- Two year age categories (12, 14, and 16) 
- Vitamin D (IU) 
- Zinc intake (mg) 
Post-Menarcheal Subjects 
OBS SUBJ AGE TWO YR RACE ZN PRO AN PRO E EZN RNASE AP 
1 2 189 16 1 9.3 61 35.1 2178 5.7 4.73333 2.45 
2 4 187 16 1 8.0 65 32.0 2605 7.7 5.33333 2.92 
3 5 162 14 1 6.8 47 47.4 1170 7.6 4.86667 2.83 
4 6 189 16 1 1o.1 60 44.8 1622 7.7 4.93333 2.56 
5 8 193 16 1 6. 1 33 22.4 1078 9.6 4.73333 2.01 
6 10 163 14 1 5.0 32 20.2 1195 11. 7 4.93333 3.42 
7 11 189 16 1 5.3 32 19.9 1109 9.8 4.73333 2.51 
8 12 193 16 1 10.5 62 51.8 1271 11.0 4.40000 1.01 
9 13 172 14 1 7.6 53 31. 7 1572 9. 1 4.66667 1. 81 
10 14 165 14 1 15.6 94 64.7 2368 10.2 5.26667 8.90 
11 15 164 14 1 14.3 90 69.6 2124 6.8 4.53333 4. 13 
12 16 162 14 1 6.8 69 53.8 1132 9.9 4.53333 3.49 
13 17 175 14 1 18. 1 105 78.3 2188 7.0 3.53333 4.96 
14 18 162 14 1 5.9 36 25.6 1005 6.8 5.33333 3.55 
15 21 193 16 1 6.9 39 29.1 1291 8.5 3.73333 2.27 
16 22 193 16 1 15.6 80 58.0 2035 8.2 4.80000 2.33 
17 23 179 14 1 4. 1 34 20.4 949 7.5 4.66667 2.73 
18 24 174 14 1 5.2 34 26.9 1198 7.3 4.46667 3.08 
19 25 173 14 1 5.3 36 23.2 1085 8.5 4.86667 1.44 
20 26 198 16 1 8.7 85 51.3 2488 10.0 4.73333 2.60 
21 27 173 14 1 5.6 42 29.3 818 8.8 5.46667 2.27 
22 28 195 16 1 24.8 70 39.9 2512 7.6 5.26667 2. 15 
23 29 164 14 1 7.7 49 28.0 1138 5.8 5.33333 3.91 
24 30 173 14 1 9.5 56 41. 7 1483 7.3 4.66667 2.86 
25 32 188 16 1 10.5 82 52.3 2067 8.0 5.20000 2.25 
26 34 188 16 1 15.4 64 41.4 2458 4.9 5.20000 3. 11 
27 35 172 14 1 9. 1 59 39.3 1673 7.5 4.66667 2.07 
28 37 189 16 1 7.0 61 46.6 1976 6.7 5.06667 2.04 
29 39 168 14 2 15.0 104 56.8 2538 8.2 5.20000 3. 12 
30 41 147 12 1 33.4 72 50.5 1472 6.2 4.86667 4.40 
31 42 169 14 1 11.0 75 54.3 1657 7.9 5.86667 2.26 
32 45 188 16 1 9.6 53 33.8 1723 7.9 5.86667 2.01 
33 IJ7 191 16 1 13. 1 68 51.6 1739 7.6 4.80000 2.63 
34 48 190 16 1 3.8 32 17 .1 1418 11. 1 6.20000 2.33 
35 49 196 16 1 3.3 20 15.7 822 11. 4 4.73333 1.57 
36 50 174 14 1 3.5 27 17.0 948 7.3 6.73333 1.44 
37 53 190 16 1 9.5 59 45.1 1551 9.8 4.93333 1.02 
38 54 186 16 1 4.5 38 19. 1 1081 13.2 5.53333 3.02 
39 56 187 16 1 11.4 74 41.8 1747 10.0 5.60000 2.50 
40 60 168 14 1 14.3 80 64.8 2298 7.6 4.20000 3.49 
41 64 168 14 1 6.9 49 28.3 1647 5.6 4.80000 3.09 
42 66 150 12 1 6.0 44 30.8 1429 6.7 4.73333 3.95 
43 68 174 14 1 9.3 56 34.8 1749 7.0 5.20000 3.71 
44 72 198 16 1 1.6 17 10.3 483 5.6 4.46667 1. 68 \0 
45 74 141 12 2 7.7 49 34.9 1904 4.0 5.06667 7. 18 N 
46 75 197 16 1 6. 1 60 39.0 1480 6.2 4.60000 1.88 
47 77 166 14 1 3.9 42 26.6 999 5.6 4.86667 3.73 
48 78 192 16 1 6. 1 60 46.2 1195 7.8 5.66667 2.01 
OB3 SUPJ AGE TWO YR RACE ZN PRO AN PRO E EZN RN ASE AP 
49 81 163 14 2 14.0 72 54. 1 1751 8. 1 7.46667 2. 38 
50 82 170 14 2 9.4 54 28.5 1959 8.0 4.13333 3. 15 
51 83 171 14 1 12.2 72 45.3 2074 7.3 4.66667 1. 73 
52 85 157 14 2 15.9 69 52.1 2353 8.6 4.13333 2.72 
53 86 170 14 2 21.9 67 48.6 2337 8.4 4.26667 2.54 
54 87 168 14 1 7.8 48 34.2 1614 5. 1 4.66667 2.91 
55 92 168 14 2 6.8 66 37. 1 3676 6.2 4.86667 1. 25 
56 93 142 12 1 11. 3 78 37.4 2119 6.5 5.66667 3.50 
57 94 140 12 1 7.5 58 36.2 1832 5.5 5.40000 2.79 
58 96 149 12 2 11. 7 68 37.7 2513 5. 1 5.53333 2.93 
59 97 151 12 2 5.7 47 33.5 965 6.5 5.46667 1. 15 
60 99 170 14 2 9.0 51 32.5 1668 5.9 5.60000 3.40 
61 101 170 14 1 6.0 62 42.2 1824 8.5 6.80000 2. 10 
62 104 168 14 2 12.6 80 60.2 2135 4.7 3.46667 2.95 
63 106 165 14 1 8.5 50 35.0 1095 7.8 5.53333 1. 95 
64 110 168 14 1 21.0 79 58.2 2240 5.3 4.93333 3.20 
65 111 164 14 2 5.0 62 46. 1 2467 6.6 5.33333 4.37 
66 112 171 14 1 9. 1 66 29.8 2002 6.2 5.13333 3.61 
67 113 168 14 2 12.6 71 31. 3 2206 9.2 5.60000 2. 17 
68 118 153 12 2 8.0 57 43.6 1315 5.5 4.46667 2.84 
69 120 193 16 2 13.2 58 31.0 2074 7.6 4.20000 2.33 
70 121 190 16 2 8.9 60 48.5 1640 6.9 5.20000 1. 16 
71 142 196 16 2 10.6 69 46.9 1702 8.0 4.20000 2.84 
72 1113 162 14 2 4.4 39 27.6 1288 6.7 4.40000 4.79 
73 144 180 16 2 12.3 55 35.4 2219 10.4 4.53333 3.11 
74 145 158 14 2 8.8 74 41. 3 2187 7.5 3.73333 2.44 
75 146 166 14 2 12.5 70 51.9 2020 8.8 5.40000 1.94 
76 148 175 14 2 2.2 30 11. 5 1072 10.7 4.86667 3.66 
77 149 167 14 2 12.7 63 46. 1 2099 6.9 5.00000 1. 91 
78 150 169 14 1 6.0 54 35.5 2063 7.2 5.33333 2.63 
79 151 170 14 1 8. 1 71 56.2 1745 8. 1 5.00000 2. 34 
80 152 172 14 2 3.6 25 11.8 748 7.0 4.66667 2. 14 
81 153 177 14 2 11. 0 84 58.7 2825 8. 1 4.80000 3.01 
82 154 173 14 2 5.8 31 15.9 1214 8. 1 4.06667 3.53 
83 155 189 16 2 16.0 107 79.9 2482 11. 5 4.53333 2.91 
84 156 173 14 2 11. 9 72 59.6 1908 6.7 4.93333 3.59 
85 157 175 14 2 6.2 41 31. 0 1331 7.2 4.93333 1. 71 
86 158 171 14 1 9. 1 62 35.5 1852 8.5 4.73333 2.37 
87 159 192 16 2 8.5 60 42.2 1753 8.5 4.06667 2.25 
88 162 191 16 1 7.9 50 33.5 1556 8.4 5.26667 1. 31 
89 163 146 12 1 11. 8 66 47.5 1807 7.5 4.60000 4. 19 
90 166 156 14 1 11. 7 72 48.2 2375 6.7 4.73333 3.73 
91 167 166 14 1 13.8 70 51. 1 2007 7.7 3.60000 6.75 
92 169 172 14 1 9. 1 64 42.3 2349 9.7 3.66667 2.78 
93 170 168 14 1 16.3 83 66.4 1638 9.4 3.86667 2.64 
94 171 194 16 1 7.2 63 35.2 1844 11 . 3 4.33333 1.49 
95 172 178 14 1 4.9 41 22.2 1481 10.4 4.00000 2.10 \0 
96 173 190 16 1 7.3 53 36.8 1330 8.6 4.20000 1. 75 w 
97 174 191 16 1 6.3 38 25.0 1205 12.9 3.93333 2.35 
Pre-Menarcheal Subjects 
OBS SUBJ AGE TWO YR RACE ZN PRO AN PRO E EZN RN ASE AP 
98 1 146 12 1 13.7 84 52.4 2028 11.0 4.26667 5.74 
99 3 168 14 1 13.5 90 57.2 2281 7.3 4.20000 4.44 
100 9 174 14 1 10.3 67 55.1 1673 7.4 5.53333 5.06 
101 19 149 12 1 8.2 59 40.2 1628 9.9 4.86667 8.32 
102 20 165 14 1 14.7 102 87.2 2915 3.7 4.60000 9.24 
103 31 143 12 1 18.7 97 83.2 2020 7.8 4.86667 4.72 
104 33 148 12 1 16.5 96 78.4 2052 5.8 4.80000 5.96 
105 38 146 12 2 11. 5 74 49.9 2373 6.5 7.06667 5.30 
106 40 140 12 1 7.0 50 39.5 1382 4.2 5.00000 3.65 
107 43 140 12 1 16.3 98 75.7 2479 7.2 6.66667 8.25 
108 44 150 12 1 12.2 98 76.3 2727 5.5 5.20000 5.02 
109 51 150 12 1 18.4 60 39.4 2052 6.7 5.40000 4.24 
110 52 148 12 1 34.7 163 124.9 4478 5.2 4.53333 4.42 
111 57 149 12 1 8.8 62 44.4 1419 7.7 4.66667 5.84 
112 58 141 12 1 12.4 70 40.6 2123 6.7 5.46667 5.52 
113 59 144 12 1 8.8 50 36.9 1280 6.0 4.46667 5.72 
114 63 141 12 1 6.8 42 30.2 1261 5.7 4.86667 6.06 
115 65 142 12 1 11. 1 104 60.8 3040 5.8 4.46667 6.45 
116 71 143 12 1 12.5 71 48.4 2812 5.9 5.13333 6.44 
117 76 147 12 1 8.7 71 44.6 2432 5.2 4.53333 7.07 
118 79 144 12 1 6.0 45 24.9 1874 7.2 5.06667 6.03 
119 80 142 12 1 11. 4 57 38.8 1732 7.2 4.86667 6. 19 
120 84 145 12 1 32.7 184 126.2 4171 8. 1 3.93333 7.44 
121 88 171 14 1 6.8 45 29.8 1961 5.2 5.60000 3.69 
122 89 171 14 1 8.8 68 49.5 1996 7.3 4.40000 4.76 
123 91 144 12 2 11. 4 99 64.5 2600 7.2 4.73333 2.28 
124 95 146 12 1 6.9 53 32.9 1431 5.6 6.33333 2.58 
125 98 146 12 1 19. 1 96 73.6 2806 6.6 5.53333 3.61 
126 100 140 12 1 16.4 93 62.7 3032 6.9 5.46667 6.86 
127 102 151 12 1 15.0 85 65.4 1935 8.3 5.46667 6.82 
128 103 144 12 1 11. 8 70 52.2 1996 4.9 3.60000 7.68 
129 105 150 12 1 15.7 113 80.4 2777 5.2 5.73333 3.70 
130 107 150 12 2 7.5 66 34. 1 2455 7.2 4.86667 8.02 
131 108 144 12 1 3.0 19 12.8 831 7.0 6.66667 7.48 
132 109 149 12 1 9.2 61 37.2 2058 5.8 7.53333 2.60 
133 114 151 12 1 5.0 44 25.6 1957 6.8 5.20000 7. 17 
134 115 149 12 1 13.0 61 40. 1 1991 7.7 6.73333 5.85 
135 117 1116 12 1 4.7 66 44.8 1992 8.2 5.53333 7.23 
136 119 144 12 1 15.2 91 69.9 1879 9.4 4.73333 6.87 
137 147 169 14 1 10.2 56 42.0 1418 8.0 4.60000 4.62 
138 161 143 12 1 5.5 50 37. 1 1118 8.0 4.26667 7.07 
l.O 
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APPENDIX B 
STEPWISE REGRESSION MODELS FOR ZINC INTAKE 
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MAXIMUM R-SQUARE IMPROVEMENT FOR DEPENDENT VARIABLE ZN 
STEP 1 VARIABLE PRO ENTERED R SQUARE = 0.63000001 C( P) = 41.16297590 
OF SUM OF SQUARES MEAN SQUARE F PROB>F 
REGRESSION 1 2639.66316299 2639.66316299 231.57 0.0001 
ERROR 136 1550.27828629 11. 39910505 
TOTAL 137 4189.94144928 
B VALUE STD ERROR TYPE 11 SS F PROB>F 
INTERCEPT -1.32165519 
PRO 0.18226314 0. 01197733 2639.66316299 231.57 0.0001 
---------------------------------------------------------------------------------------------------------
--------THE ABOVE MODEL IS THE BEST 1 VARIABLE MODEL FOUND. 
STEP 2 VARIABLE CU ENTERED R SQUARE= 0.70970113 C( P) = 5.43139561 
OF SUM OF SQUARES MEAN SQUARE F PROB>F 
REGRESSION 2 2973.60616281 11186. 80308140 165.02 0.0001 
ERROR 135 1216.33528647 9. 00989101 
TOTAL 137 4189.94144928 
B VALUE STD ERROR TYPE 11 SS F PROB>F 
INTERCEPT -2.28910456 
PRO 0.16263424 0.01112582 1925.21731396 213.68 0.0001 
cu 1.57001147 0.25788520 333.94299982 37.06 0.0001 
THE ABOVE MODEL IS THE BEST 2 VARIABLE MODEL FOUND. 
STEP 3 VARIABLE ANPRO ENTERED R SQUARE= 0.72081869 C( P) = 2.16819113 
OF SUM OF SQUARES MEAN SQUARE F PROB>F 
REGRESSION 3 3020.18810500 1006.72936833 115.32 0.0001 
ERROR 134 1169.75334427 8.72950257 
TOTAL 137 4189.94144928 
B VALUE STD ERROR TYPE 11 SS F PROB>F 
INTERCEPT -1.93867266 
AN PRO 0.09527132 0.04124280 46.58194219 5.34 0.0224 
PRO 0.09071218 0.03300479 65.94269821 7.55 0.0068 
cu 1.62619569 0.25500335 355.01225944 40.67 0.0001 
THE ABOVE MODEL IS THE BEST 3 VARIABLE MODEL FOUND. \.0 
°' 
STEP 4 VARIABLE E ENTERED R SQUARE= 0.72245603 C( P) = 3.39305283 
OF SUM OF SQUARES MEAN SQUARE F PROB>F 
REGRESSION 4 3027.04845935 756.76211484 86.55 0.0001 
ERROR 133 1162.89298993 8.74355632 
TOTAL 137 4189.94144928 
B VALUE STD ERROR TYPE 11 SS F PROB>F 
INTERCEPT -2.18617962 
AN PRO o. 11043469 0.04468502 53.40417734 6.11 0.0147 
PRO 0.06455534 0.04430644 18.56173942 2. 12 0.1475 
cu 1.62615562 0.25520853 354.99475600 40.60 0.0001 
E 0.00067811 0.00076554 6.86035435 0.78 0.3773 
------------------------------------------------------------------------------------------------------
-----------
THE ABOVE MODEL IS THE BEST 4 VARIABLE MODEL FOUND. 
STEP 5 VARIABLE FIB ENTERED R SQUARE= 0.72370222 C( P) = 4.80308996 
OF SUM OF SQUARES MEAN SQUARE F PROB>f 
REGRESSION 5 3032.26992024 606.45398405 69.15 0.0001 
ERROR 132 1157.67152903 8.77023886 
TOTAL 137 4189.94144928 
B VALUE STD ERROR TYPE 11 SS F PROB>F 
INTERCEPT -2.12376285 
AN PRO 0.10237129 0.04595708 43. 51740397 4.96 0.0276 
PRO 0.07574063 0.04668184 23.08731044 2.63 o. 1071 
cu 1.64377038 0.25661512 359.85641706 41.03 0.0001 
E 0.00069623 0.00076707 7.22515204 0.82 0.3657 
FIB -o. 19177276 0.24854019 5.22146090 0.60 0.4417 
THE ABOVE MODEL IS THE BEST 5 VARIABLE MODEL FOUND. 
~ 
....... 
~TEP 6 VARIABLE CA ENTERED R SQUARE= 0.72464879 C( p) = 6.35497000 
Df SUM Of SQUARES MEAN SQUARE F PROB>F 
6 3036. 23600172 506.03933362 57.46 0.0001 lffGRESS I ON 1153.70544755 8.80691181 ERROR 13 1 
TOTAL 137 4189. 941l14928 
B VALUE STD ERROR TYPE II SS f PROB>f 
INTERCEPT -2.05212185 0. 011618471 115. 269061119 5. 111 0.0250 AN PRO o. 101l70979 2.63 0.09117 0.079241118 0.04706977 211. 96169962 PHO 
1.61177356 0. 261531106 334.46382793 37 .98 0.0001 cu 0.99 0. 3205 0. 00077551 0.00077770 8.75742437 [ 3.96608148 0.45 0. 50311 CA -0.00062871 0.00093687 0,55 0,4589 FIB -o. 16517207 0.24925344 4.86062685 
----------------------------------------------------------------------------------------------------
HIE ABOVE MODEL IS TllE BEST 6 VARIABLE MODEL FOUND. 
STEP 7 VARIABLE MG ENTERED R SQUARE= 0.72539860 C( P) = 8.00000000 
OF SUM Of SQUARES MEAN SQUARE f PROB>F 
REGRESSION 7 3039. 377660112 434.19680863 t19. 06 0.0001 LRROR 130 1150. 56378886 8.850lt9068 TOTAL 137 4189. 91111111926 
B VALUE STD ERROR TYPE 11 SS F PROB>F 
INTERCEPT -2. 05610726 
AN PRO 0.11038724 0.011726932 46.26656464 5.45 0.0211 PRO 0. 01117140 0. 011909296 18.60115168 2.10 0.11195 cu 1.59331018 0. 26110054 7 322.36075008 36. t12 0.0001 E 0.00068666 0.00079376 6.62324891 0.75 0.3886 CA 
-0.00105786 0.00118360 7.06991lt05 0.60 0.3731 MG 0. 005117956 0.00919707 3.11f165669 0.35 0.5523 FIB -o. 312117501 0.32876948 7.99493507 0.90 0.31137 
lllE ABOVE MODEL IS TllE BEST 7 VARIABLE MODEL FOUND. 
\0 
00 
APPENDIX C 
STEPWISE REGRESSION MODELS FOR ERYTHROCYTE 
ZINC CONCENTRATION 
99 
MAXIMUM R-SQUARE IMPROVEMENT FOR DEPENDENT VARIABLE EZN 
WARNING: 3 OBSERVATIONS DELETED DUE TO MISSING VALUES. 
STEP 1 VARIABLE AGE ENTERED R SQUARE= 0.18732483 C( P) = 1.38976833 
DF SUM OF SQUARES MEAN SQUARE 
REGRESSION 1 81.73085059 81.73085059 
ERROR 133 354.57463090 2.66597467 
TOTAL 134 436.30548148 
B VALUE STD ERROR TYPE 11 SS 
INTERCEPT 0. 10185976 
AGE 0.04479666 0.00809060 81.73085059 
THE ABOVE MODEL IS THE BEST 1 VARIABLE MODEL FOUND. 
STEP 2 VARIABLE E ENTERED R SQUARE = 0.20150679 C( P) = 1.07944038 
DF SUM OF SQUARES MEAN SQUARE 
REGRESSION 2 87.91851666 43.95925833 
ERROR 132 348.38696482 2.63929519 
TOTAL 134 436. 305481118 
B VALUE STD ERROR TYPE 11 SS 
INTERCEPT 1.35372901 
AGE 0.04124978 0.00837668 64.00110354 
E -0.00035854 0.00023417 6.18766607 
TllE ABOVE MODEL IS THE BEST 2 VARIABLE MODEL FOUND. 
F 
30.66 
F 
30.66 
F 
16.66 
F 
24.25 
2. 34 
PROB>F 
0.0001 
PROB>F 
0.0001 
PROB>F 
0.0001 
PROB>F 
0.0001 
0. 1281 
f-' 
0 
0 
STEP 3 VARIABLE PRO ENTERED R SQUARE = 0.22052683 C( p) = -0.01904143 
OF SUM OF SQUARES MEAN SQUARE f PROB>F 
REGRESSION 3 96.21706615 32.07235538 12.35 0.0001 
ERROR 131 340.08841533 2.59609477 
TOTAL 134 436.30548148 
B VALUE STD ERROR TYPE 11 SS F PROB>f 
INTERCEPT 1.05407533 
AGE 0. 01126077 6 0. 008311249 67. 71837063 26.08 0.0001 
PRO 0.01972418 0.01103210 8.29854949 3.20 0.0761 
E -0.00100313 0.00042886 14.20406266 5.47 0.0208 
-----------------------------------------------------------------------------------------------------------------
THE ABOVE MODEL IS THE BEST 3 VARIABLE MODEL FOUND. 
STEP 4 VARIABLE RHT ENTERED R SQUARE = 0.23002478 C( P) = 0.43368439 
OF SUM OF SQUARES MEAN SQUARE f PROB>F 
REGRESSION 4 100. 36107350 25.09026838 9.71 0.0001 ERROR 130 335.94440798 2.58418775 TOTAL 134 436.30548148 
B VALUE STD ERROR TYPE 11 SS F PROB>F 
INTERCEPT 6.59889864 
RHT -0.05166066 0.04079545 4. 1411007 35 1. 60 0.2077 AGE 0.04049955 0.00848820 58.82924450 22.77 0.0001 PRO 0.02058772 0.01102787 9.00652104 3. ll9 0.0642 E -0.00104854 0.00042937 15, IJ 1087517 5.96 0.0159 
THE ABOVE MODEL IS THE BEST 4 VARIABLE MODEL FOUND. 
I-' 
0 
I-' 
STEP 5 VARIABLE HB ENTERED R SQUARE = 0.23760259 C( P) = 1.19921241 
OF SUM OF SQUARES MEAN SQUARE F PROB>F 
REGRESSION 5 103. 6673142LI 20.73346285 8.04 0.0001 
ERROR 129 332.63816724 2.57859044 
TOTAL 134 436.30548148 
B VALUE STD ERROR TYPE 11 SS F PROB>F 
INTERCEPT 9.46196498 
HB -o. 18175378 0.16051196 3.30624074 1.28 0.2596 
RIH -0.05271850 0.04076195 4.31319038 1.67 0. 1982 
AGE 0.03915728 0.00856146 53.94008637 20.92 0.0001 
PRO 0.01868757 0.01114300 7.25242664 2.81 0.0960 
E -0.00101144 0.00043016 14.25622881 5.53 0.0202 
-------------------------------------------------------------------------------------------------------
----------
THE ABOVE MODEL IS THE BEST 5 VARIABLE MODEL FOUND. 
STEP 6 VARIABLE MUSC ENTERED R SQUARE= 0.24139855 C( P) = 2.58082819 
OF SUM OF SQUARES MEAN SQUARE F PROB>F 
REGRESSION 6 105.32350988 17.55391831 6.79 0.0001 
ERROR 128 330.98197160 2.58579665 
TOTAL 134 436.30548148 
B VALUE STD ERROR TYPE 11 SS F PROB>F 
INTERCEPT 9.51947761 
HB -o. 17678909 0.16085575 3.12343237 1. 21 0.2738 
RHT -0.04885293 0.04110364 3.65270825 1.41 0.2368 
MUSC -0.00015881 0.00019843 1.65619564 0.64 0.4250 
AGE 0.03971773 0.00860197 55.12739263 21.32 0 .. 0001 
PRO 0. 01713409 0.01132614 5.91769893 2.29 0.1328 
E -o. 00102101 0.00043092 14.51630747 5.61 0.0193 
---------------------------------------------------------------------------------------------------------
--------
THE ABOVE MODEL IS THE BEST 6 VARIABLE MODEL FOUND. 
I-' 
0 
N 
SIEP 7 VARIABLE SPRO ENTERED R SQUARE = 0.24609603 C( p) = 3.81557937 
OF SUM OF SQUARES MEAN SQUARE F PROB>F 
REGRESSION 7 107.37304757 15.33900680 5.92 0.0001 
ERROR 127 328.93243391 2.59001916 
TOTAL 134 436.30548148 
B VALUE STD ERROR TYPE 11 SS F PROB>F 
INTERCEPT 11.53476747 
SPRO -0.27794166 0.31244760 2.04953769 0.79 0.3754 
HB -0.17480240 0.16100252 3.05303925 1.18 0.2797 
RHT -0.04834709 0.04114112 3.57677281 1. 38 0.2421 
MUSC -0.00019082 0.00020183 2.31517084 0.89 0.3462 
AGE 0.04047331 0.00865079 56.69293995 21.89 0.0001 
PRO 0.01681438 0.01134108 5.69319429 2.20 o. 1407 
E -0.00105504 0.00043297 15.37898293 5.94 0.0162 
-----------------------------------------------------------------------------------------------------------------
THE ABOVE MODEL IS THE BEST 7 VARIABLE MODEL FOUND. 
STEP 8 VARIABLE PCINC ENTERED R SQUARE = 0.24818060 C( P) = 5.47599062 
OF SUM OF SQUARES MEAN SQUARE F PROB>F 
REGRESSION 8 108.28255557 13.53531945 5.20 0.0001 
ERROR 126 328.02292591 2.60335655 
TOTAL 134 436. 305li8148 
B VALUE STD ERROR TYPE I I SS F PROB>F 
INTERCEPT 11.85427537 
SPRO -0.26341138 0.31421417 1.82957899 0.70 0.4034 
HB -0. 19580150 0.16528006 3.65363159 1. 40 0.2384 
RHT -0.05223176 0.04176725 4.07128223 1.56 0.2134 
MUSC -0.000195118 0.00020250 2.42602628 0.93 0.3362 
AGE 0.04077871 0.008688111 57.34820634 22.03 0.0001 
PCINC 0.00002905 0.00004915 0.90950801 0.35 0.5555 
PRO 0.01790907 0.01152009 6.29169895 2. Li2 o. 1226 
E -0.00107111 0.00043493 15.78918090 6.06 0.0151 
-----------------------------------------------------------------------------------------------------------------
THE ABOVE MODEL IS THE BEST 8 VARIABLE MODEL FOUND. 
I-' 
0 
w 
STEP 9 VARIABLE SKFD ENTERED R SQUARE = 0.25013550 C( P) = 7.15752554 
OF SUM OF SQUARES MEAN SQUARE F PROB>F 
REGRESSION 9 109.13548883 12.12616543 4.63 0.0001 
ERROR 125 327.16999265 2.61735994 
TOTAL 134 436.30548148 
B VALUE STD ERROR TYPE I I SS F PROB>F 
INTERCEPT 12.3lt547354 
SPRO -0.27912056 0.31625764 2.03875512 0.78 0.3792 
HB -0.20263597 0.16615588 3.89282684 1. 49 0.2249 
RHT -o. 05566610 0.04230935 4.53077467 1. 73 0. 1907 
SKFU 0.01226256 0.02148104 0. 85293326 0.33 0.5691 
MUSC -0.00020819 0.00020426 2.71901980 1.04 0.3101 
AGE 0.03974964 0.00889630 52.25292393 19.96 0.0001 
PCINC 0. 000028111 0.00004929 0.86966578 0.33 0.5654 
PRO 0.01671253 0. 01173967 5.30440158 2.03 0. 1571 
E -0.00100594 0.00045080 13.03297912 4.98 0.0274 
-----------------------------------------------------------------------------------------------------------------
THE ABOVE MODEL IS THE BEST 9 VARIABLE MODEL FOUND. 
STEP 10 VARIABLE ZN ENTERED R SQUARE = 0.25069736 C( P) = 9.06599524 
OF SUM OF SQUARES MEAN SQUARE F PROB>F 
REGRESSION 10 109.38063108 10.93806311 4.15 0.0001 
ERROR 124 326.92485041 2.63649073 
TOTAL 134 436.30548148 
B VALUE STD ERROR TYPE 11 SS F PROB>F 
INTERCEPT 12.030251163 
SPRO -0.27535837 0. 31765103 1.98117243 0.75 0. 3877 
HB -o. 20041065 0.16692161 3.80051718 1.44 0.2322 
RHT -0.05361752 0.04299186 4.10078681 1. 56 0.2147 
SKFD 0.01398224 0.02228482 1.03791378 0.39 0.5315 
MUSC -o. 00020911 0.00020503 2.74255812 1.04 0.3098 
AGE 0.03971817 0.00892935 52.16327282 19.79 0.0001 
PCINC 0. 000027911 0.00004950 0.84030713 0.32 0.5734 
PRO 0.01877411 0.013581143 5.03572779 1. 91 0. 1694 
E -0.00098545 0.00045740 12.23772031 4.64 0.0331 
ZN -0.01338311 0.04388953 0.24514225 0.09 0.7609 
-----------------------------------------------------------------------------------------------------------------
THE ABOVE MODEL IS THE BEST 10 VARIABLE MODEL FOUND. I-' 
0 
~ 
APPENDIX D 
STEPWISE REGRESSION MODELS FOR PLASMA 
RIBONUCLEASE 
105 
MAXIMUM R-SQUARE IMPROVEMENT FOR DEPENDENT VARIABLE RNASE 
WARNING: 3 OBSERVATIONS DELETED DUE TO MISSING VALUES. 
STEP 1 VARIABLE AGE ENTERED R SQUARE = 0.03165186 C( p) = -2.64816226 
OF SUM OF SQUARES MEAN SQUARE 
REGRESSION 1 2.37886921 2.37886921 
ERROR 133 72.77846412 0.54720650 
TOTAL 134 75. 15733333 
B VALUE STD ERROR TYPE 11 SS 
INTERCEPT 6.23404040 
AGE -0.00764254 0.00366546 2.37886921 
THE ABOVE MODEL IS THE BEST 1 VARIABLE MODEL FOUND. 
STEP 2 VARIABLE PRO ENTERED R SQUARE = 0.05781569 C( p) = -4. 11610500 
OF SUM OF SQUARES MEAN SQUARE 
REGRESSION 2 4.34527305 2.17263652 
ERROR 132 70.81206029 0.53645500 
TOTAL 134 75. 15733333 
B VALUE STD ERROR TYPE 11 SS 
INTERCEPT 6.90631499 
PRO -o. 005199118 0.00271575 1.96640383 
AGE -o. 009681115 0.00378229 3.51483128 
THE ABOVE MODEL IS THE BEST 2 VARIABLE MODEL FOUND. 
F 
4.35 
F 
4.35 
F 
4.05 
F 
3.67 
6.55 
PROB>F 
0.0390 
PROB>F 
0.0390 
PROB>F 
0.0196 
PROB>F 
0.0577 
0.0116 
f--' 
0 
°' 
STEP 3 VARIABLE SKFD ENTERED R SQUARE = 0.06816701 C( P) = -3.48814395 
OF SUM OF SQUARES MEAN SQUARE F PROB>F 
REGRESSION 3 5.12325090 1.70775030 3. 19 0.0255 
ERROR 131 70.03408243 0.53461132 
TOTAL 134 75.15733333 
B VALUE STD ERROR TYPE 11 SS F PROB>F 
INTERCEPT 6. 99274100 
SKFD -o. 01102091 0.00913593 0.77797786 1.46 0.2299 
PRO -0.00561788 0.00273318 2.25863565 4.22 0.0418 
AGE -0.00879201 0.00384710 2.79220891 5.22 0.0239 
-----------------------------------------------------------------------------------------------------------------
THE ABOVE MODEL IS THE BEST 3 VARIABLE MODEL FOUND. 
SlEP 4 VARIABLE MENS ENTERED R SQUARE = 0.07650946 C( P) = -2.59391169 
DF SUM OF SQUARES MEAN SQUARE F PROB>F 
REGRESSION 4 5.75024682 1.43756171 2.69 0.0338 
ERROR 130 69.40708651 0.53390067 
TOTAL 134 75.15733333 
B VALUE STD ERROR TYPE I I SS F PROB>F 
INfERCEPT 6.21481792 
SKFD -0.01041784 0.00914680 0.69259146 1. 30 0.2568 
PRO -0.00618362 0.00278081 2.64000259 lj. 94 0.0279 
AGE -0.00555428 0.00486897 o. 69477117 1. 30 0.2561 
MENS o. 20286110 0.18719604 0.62699592 1. 17 0.2805 
-----------------------------------------------------------------------------------------------------------------
THE ABOVE MODEL IS HIE BEST 11 VAR I ABLE MODEL FOUND. 
f-' 
0 
--i 
STEP 5 VARIABLE PCINC ENTERED R SQUARE = 0.08079976 C( P) = -1.16257946 
OF SUM OF SQUARES MEAN SQUARE F PROB>F 
REGRESSION 5 6.07269461 1.21453892 2.27 0.0510 ERROR 129 69.08L163872 0.53553984 TOTAL 134 75.15733333 
B VALUE STD ERROR TYPE 11 SS F PROB>F 
INTERCEPT 5.95468204 
SKFD -0.01065744 0.00916603 0.72399349 1. 35 0.2471 PRO 
-0.00572661 0.00284666 2.16727524 4.05 0.0463 AGE 
-0.00487101 0.00495531 o. 51747487 0.97 0.3275 MENS 0.22030815 0.18882666 0.72899790 1. 36 0.2455 PCINC 0.00001671 0.00002153 0.32244779 0.60 0.4392 
-----------------------------------------------------------------------------------------------------------------
THE ABOVE MODEL IS THE BEST 5 VARIABLE MODEL FOUND. 
STEP 6 VARIABLE E ENTERED R SQUARE = 0.08271962 C( P) = 0.58294870 
OF SUM OF SQUARES MEAN SQUARE F PROB>F 
REGRESSION 6 6.21698604 1.03616434 1.92 o. 0817 ERROR 128 68. 91t034729 0.53859646 TOTAL 134 75.15733333 
B VALUE STD ERROR TYPE 11 SS F PROB>F 
INTERCEPT 5.91501232 
SKFD -0.00935281 0.00953147 0.518591J26 0.96 0.3283 PRO 
-0.0079681J7 0.00518749 1.27086172 2.36 0. 1270 E 0.00010558 0.00020399 0.14429142 0.27 0.6056 AGE -0.00498610 0. 004974L1Q 0.54113221 1.00 0.3181 MENS 0.21196789 0. 19004910 0.66999571 1. 24 0.2668 PCINC 0.00001566 0.00002169 0.28103772 0.52 0.4714 
-----------------------------------------------------------------------------------------------------------------
lHE ABOVE MODEL IS THE BEST 6 VARIABLE MODEL FOUND. 
f--' 
0 
CX> 
STEP 7 VARIABLE SPRO ENTERED 
REGRESSION 
ERROR 
TOTAL 
INTERCEPT 
SPRO 
SKFD 
PRO 
E 
AGE 
MENS 
PCINC 
R SQUARE = 0.08466024 
DF 
7 
127 
134 
B VALUE 
5.35709452 
0.07353607 
-0.00969349 
-0.00789212 
0.00011079 
-0.00500805 
0.21823953 
0.00001674 
SUM OF SQUARES 
6.36283811 
68.79449522 
75. 15733333 
STD ERROR 
0.14171608 
0.00958132 
0.00520444 
0.00020482 
0.00498884 
0.19097677 
0.00002185 
THE ABOVE MODEL IS THE BEST 7 VARIABLE MODEL FOUND. 
STEP 8 VARIABLE EZN ENTERED 
REGRESSION 
ERROR 
TOTAL 
INTERCEPT 
SPRO 
EZN 
SKFD 
PRO 
E 
AGE 
MENS 
PCINC 
R SQUARE = 0.08569294 
DF 
8 
126 
134 
B VALUE 
5. 39.133004 
0.07016895 
-0.01514192 
-0.00963695 
-0.00759597 
0.00009538 
-0.00433914 
0.21937676 
0.00001682 
SUM OF SQUARES 
6.44045283 
68.71688051 
75. 15733333 
STD ERROR 
o. 14247690 
0.04013798 
0.00961500 
0.00528078 
0.00020954 
0.00531053 
0.19164864 
0.00002192 
THE ABOVE MODEL IS THE BEST 8 VARIABLE MODEL FOUND. 
C( P) = 2.32572451 
C(P) 
MEAN SQUARE 
0.90897687 
0.54168894 
TYPE 11 SS 
0.14585207 
0.55444636 
1.24562759 
0.15848507 
0.54586798 
0.70738481 
0.31804642 
4.18884347 
MEAN SQUARE 
0.80505660 
0.54537207 
TYPE 11 SS 
0.13227992 
0.077611172 
0.54786406 
1.12840102 
0.11300497 
0.36410275 
0.71459944 
0.32104895 
F 
1.68 
F 
0.27 
1. 02 
2.30 
0.29 
1. 01 
1. 31 
0.59 
F 
1.48 
F 
0.24 
0. 1 !1 
1. 00 
2.07 
0.21 
0.67 
1. 31 
0.59 
PROB>F 
0.1193 
PROB>F 
0.6047 
0.3136 
0.1319 
0.5895 
0. 3174 
0.2553 
0.4449 
PROB>F 
0.1723 
PROB>F 
0.6232 
0.7066 
0.3181 
0. 1528 
0.6497 
0.4154 
0.2545 
0.4444 
I-' 
0 
'° 
SHP 9 VARIABLE RACE ENTERED R SQUARE = 0.08610398 C( P) = 6.13436169 
DF SUM OF SQUARES MEAN SQUARE F PROB>F 
REGHESSION 9 6.47134526 0.71903836 1. 31 0.2384 
ERROR 125 68.68598808 0.54948790 
TOTAL 1311 75.15733333 
B VALUE STD ERROR TYPE I I SS F PROB>F 
INTERCEPT 5.52052677 
SPRO 0.07106805 0.14306377 0. 13559624 0.25 0.6202 
EZN -0.01497628 0.04029521 0.07590304 0. 14 0. 7108 
SKFD -0.00977999 0.00967005 0.56205275 1.02 0.3138 
PRO -0.00787695 0.00543152 1.15566580 2. 10 o. 1495 
E 0.00010805 o·.00021101 0. 13623008 0.25 0.6194 
AGE -0.00466161 0.00550129 0.39454850 0.72 0. 3984 
MENS 0.20020909 0.20866571 0.50585210 0.92 0.3392 
RACE -o. Olt 126564 0. 17403700 0.03089243 0.06 0.8130 
PCINC 0.00001507 0.00002321 0.23145892 0.42 0. 5175 
-----------------------------------------------------------------------------------------------------------------
THE ABOVE MODEL IS THE BEST 9 VARIABLE MODEL FOUND. 
STEP 10 VARIABLE MUSC ENTERED R SQUARE = 0.08662198 C( P) = 8.06570208 
OF SUM OF SQUARES MEAN SQUARE F PROB>F 
REGRESSION 10 6.51027685 o. 65102768 1. 18 0.3133 
ERROR 124 68.64705648 0.55360529 
TOTAL 134 75.15733333 
B VALUE STD ERROR TYPE 11 SS F PROB>F 
INTERCEPT 5. 37711025 
SPRO 0.07928413 0.14690306 0.16125421 0.29 0.5904 
EZN -0.01381711 0.04068141 0.06386205 0. 12 0.7347 
SKFD -0.01014593 0.00980382 0.59291638 1. 07 0.3027 
MUSC 0.00002591 0.00009770 0.03893159 0.07 0.7913 
PRO -0.00770653 0.00548957 1.09104056 1.97 o. 1629 
E 0.00011262 0.00021850 0.14706070 0.27 0.6072 
AGE -0.00470265 0.00552403 0.40121222 0.72 0.3962 
MENS 0.204514011 0.21007421 0.52468788 0.95 0.3322 
RACE -0.05148212 0.17888562 0.04585241 0.08 0. 7740 
PCINC 0.00001442 0.00002343 0.20987708 0.38 0.5392 
-----------------------------------------------------------------------------------------------------------------
THE ABOVE MODEL IS THE BEST 10 VARIABLE MODEL FOUND. 
t-' 
t-' 
0 
APPENDIX E 
STEPWISE REGRESSION MODELS FOR SERUM 
ALKALINE PHOSPHATASE 
111 
MAXIMUM R-SQUARE IMPROVEMENT FOR DEPENDENT VARIABLE AP 
WARNING: 2 OBSERVATIONS DELETED DUE TO MISSING VALUES, 
SHP 1 VARIABLE MENS ENTERED R SQUARE = 0.48804309 C( p) = 36.53371346 
DF SUM OF SQUARES MEAN SQUARE 
REGRESSION 1 240. 60115103 240.60115103 
ERROR 134 252.39046000 1.88351090 
TOTAL 135 492.99161103 
B VALUE STD ERROR TYPE 11 SS 
INTERCEPT -0.10850000 
MENS 2.91912500 0.25827829 240.60115103 
THE ABOVE MODEL IS THE BEST 1 VARIABLE MODEL FOUND. 
STEP 2 VARIABLE AGE ENTERED R SQUARE = 0.55334807 C( P) = 17.03563504 
DF SUM OF SQUARES MEAN SQUARE 
REGRESSION 2 272.79595520 136.39797760 
ERROR 133 220.19565583 1.65560643 
TOTAL 135 492.99161103 
B VALUE STD ERROR TYPE I I SS 
INTERCEPT 7.33223659 
AGE -0.03737264 0.00847499 32. 19480417 
MENS 1.98395258 0.32188407 62.89566489 
THE ABOVE MODEL IS THE BEST 2 VARIABLE MODEL FOUND. 
F 
127.74 
F 
127.74 
F 
82. 39 
F 
19.45 
37.99 
PROB>F 
0.0001 
PROB>F 
0.0001 
PROB>F 
0.0001 
PROB>F 
0.0001 
0.0001 
~ 
~ 
N 
STEP 3 VARIABLE VD ENTERED R SQUARE= 0.58411735 C( P) = 8.90653867 
DF SUM OF SQUARES MEAN SQUARE F PROB>F 
REGRESSION 3 287.96495160 95.98831720 61. 80 0.0001 
ERROR 132 205.02665943 1.55323227 
TOTAL 135 492.99161103 
B VALUE STD ERROR TYPE 11 SS F PROB>F 
INTERCEPT 6.78759193 
VD 0.00182768 0.00058484 15.16899639 9.77 0.0022 
AGE -0.03602750 0.00822007 29.83692150 19.21 0.0001 
MENS 1.89757134 0.31299638 57.08920715 36.76 0.0001 
-----------------------------------------------------------------------------------------------------------------
TllE ABOVE MODEL IS THE BEST 3 VARIABLE MODEL FOUND. 
STEP 4 VARIABLE RNASE ENTERED R SQUARE= 0.60761785 C( P) = 3.17028821 
DF SUM OF SQUARES MEAN SQUARE F PROB>F 
REGRESSION 4 299.55050189 74.88762547 50.71 0.0001 
ERROR 131 193.44110914 1.47664969 
TOTAL 135 492.99161103 
B VALUE STD ERROR TYPE I I SS F PROB>F 
INTERCEPT 9.05912057 
HNASE -0. 3999372t1 0.14278160 11.58555030 7.85 0.0059 
VD 0.00178881 0.00057041 14.52210536 9.83 0.0021 
AGE -0.03814729 0.00805051 33.15571051 22.45 0.0001 
MENS 1.95511924 0.30587343 60.33099173 40.86 0.0001 
TllE ABOVE MODEL IS THE BEST 4 VARIABLE MODEL FOUND. 
I-' 
I-' 
w 
STEP 5 VARIABLE MUSC ENTERED R SQUARE = 0.62087504 C( P) = 0.80608588 
OF SUM OF SQUARES MEAN SQUARE F PROB>F 
REGRESSION 5 306.08618552 61.21723710 42.58 0.0001 ERROR 130 186. 905112551 1.43773404 
TOTAL 135 1192. 99161103 
B VALUE STD ERROR TYPE 11 SS F PROB>F 
INTERCEPT 10.28539247 
RNASE -0.38234427 o. 14112903 10.55249082 7.34 0.0077 VD 0.00149617 0.000579311 9.58902552 6.67 0.0109 MUSC -0.00031006 0. 000145113 6.53568363 4.55 0.0349 AGE -0.03879111 0.00794946 31.1. 231183193 23.81 0.0001 
MENS 1.81367477 0.30902103 49.52463890 34.45 0.0001 
-----------------------------------------------------------------------------------------------------------------
TllE ABOVE MODEL IS TllE BEST 5 VARIABLE MODEL FOUND. 
SlEP 6 VAR I ABLE PC I NC ENTERED R SQUARE = 0.62793745 C( P) = 0.48117335 
Of SUM Of SQUARES MEAN SQUARE F PROB>f 
H[GRESSION 6 309.56789687 51 . 591164948 36.29 0.0001 ERROR 129 183.42371416 1.42188926 
TOTAL 135 492. 99161103 
B VALUE STD ERROR TYPE 11 SS f PROB>f 
INTERCEPT 9. 791183353 
RN ASE -o. 110316252 0. 111097835 11.62843336 8. 18 0. 00119 VD 0.0011151143 0.00057676 9.04210548 6.36 0.0129 MUSC -0.00033726 0.000111566 7.62251469 5.36 0.0222 AGE -0.03709"119 0.00797930 30.73393479 21.61 0.0001 
MENS 1.87986566 0. 31021095 52.21618837 36.72 0.0001 PCINC 0. 000051110 0.00003457 3.48171135 2.45 0. 1201 
-----------------------------------------------------------------------------------------------------------------
Tiff ABOVE MODEL. IS TllE BEST 6 VARIABLE: MODEL IOUNO. 
I-'. 
I-' 
~ 
STEP 7 VARIABLE RHT ENTERED R SQUARE = 0.62976132 C( P) = 1.88076516 
OF SUM OF SQUARES MEAN SQUARE F PROB>F 
REGRESSION 7 310.46704813 44.35243545 31.10 0.0001 
ERROR 128 182.52456290 1.42597315 
TOTAL 135 492.99161103 
B VALUE STD ERROR TYPE II SS F PROB>F 
INTERCEPT 12.67636586 
RNASE -0.40464662 0.14119304 11.71215014 8.21 0.0049 
VD 0.00148928 0.00057925 9.42617706 6.61 0.0113 
RHT -o. 02513115 0.03164839 0.89915126 0.63 0.4286 
MUSC -0.00032978 0.00014618 7.25743537 5.09 0.0258 
AGE -0.03908996 0.00837556 31.06091519 21.78 0.0001 
MENS 1.81976372 0.31974351 46.18892592 32.39 0.0001 
PCINC 0.00005697 0.00003481 3.81904109 2.68 0. 1042 
-----------------------------------------------------------------------------------------------------------------
THE ABOVE MODEL IS THE BEST 7 VARIABLE MODEL FOUND. 
STEP 8 VARIABLE SKFD ENTERED R SQUARE = 0.63082150 C( P) = 3.53175797 
DF SUM OF SQUARES MEAN SQUARE F PROB>F 
REGRESSION 8 310.98970964 38.87371370 27. 13 0.0001 
ERROR 127 182.00190139 1.43308584 
TOTAL 135 1192. 99161103 
B VALUE STD ERROR TYPE 11 SS F PROB>F 
INTERCEPT 12.40932434 
RNA SE -0.412607112 0.14215723 12. 07281090 8.42 0.0044 
VD 0.00143154 0.00058851 8.47954408 5.92 0.0164 
RHT -0.02196809 0.03215663 0.66883014 0.47 0.4958 
SKFD -0.00930873 0.015111404 0.52266150 0. 36 0.5470 
MUSC -0.00032180 0.00014714 6.85482986 4.78 0.0306 
AGE -0.03822253 0.00851839 28.85332360 20. 13 0.0001 
MENS 1.82275625 0. 32057825 46.32989052 32.33 0.0001 
PCINC 0.00005799 0.00003494 3.94858378 2.76 0.0994 
THE ABOVE MODEL IS THE BEST 8 VARIABLE MODEL FOUND. 
I-' 
f-' 
Vt 
STEP 9 VARIABLE E ENTERED R SQUARE = 0.63209799 C( P) = 5.11154526 
OF SUM OF SQUARES MEAN SQUARE F PROB>F 
REGRESSION 9 311.61900615 34.62433402 24.05 0.0001 
ERROR 126 181.37260487 1.43946512 
TOTAL 135 1192.99161103 
B VALUE STD ERROR TYPE II SS F PROB>F 
INTERCEPT 12.76258588 
RNASE -o. 42241114 0.14324275 12.51775909 8.70 0.0038 
E -0.00012733 0.00019258 0.62929652 0.44 0.5097 
VD 0.00155497 0.00061865 9.09387326 6.32 0.0132 
RllT -0.02149951 0.03223591 0.64029241 0.44 0.5060 
SKFD -0.01137838 0.01576224 0.75011169 0.52 0.4717 
MUSC -0.00033737 0.00014933 7.34692793 5. 10 0.0256 
AGE -0.03864758 0.00856150 29.33230179 20.38 0.0001 
MENS 1.84699429 0.32337550 46.95891262 32.62 0.0001 
PCINC 0.00005494 0.00003532 3 .118332801 2.42 0. 1223 
---------------------------------------------------------------------------------------------------------
--------
THE ABOVE MODEL IS THE BEST 9 VARIABLE MODEL FOUND. 
STEP 10 VARIABLE EZN ENTERED R SQUARE = 0.63222401 C( p) = 7.07005976 
OF SUM OF SQUARES MEAN SQUARE F PROB>F 
REGRESSION 10 311.68113345 31.16811334 21.49 0.0001 
ERROR 125 181.31047758 1.45048382 
TOTAL 135 492. 99161103 
B VALUE STD ERROR TYPE 11 SS F PROB>F 
INTERCEPT 12.64625347 
EZN 0.01360977 0.06576062 0.06212729 0.04 0.8364 
RNASE -0.42081974 0.14399540 12.38818909 8.54 0.0041 
E -0.00011987 0.00019664 0.53897020 0. 37 0.5433 
VD 0.00154099 0.00062468 8.82666246 6.09 0.0150 
RHT -o. 02077210 0.03254938 0.59072923 0.41 0.5245 
SKFD -0.01159301 0.01585640 0.77534728 0.53 0.4661 
MUSC -0.00033457 0.00015051 7.16691373 4.94 0.0280 
AGE -0.03914759 0.00892733 27.89201879 19.23 0.0001 
MENS 1 . 8117925 79 0.32464201 46.99725524 32.40 0.0001 
PCI NC 0. 000051192 0.00003545 3.48038970 2.40 o. 1239 
---------------------------------------------------------------------------------------------------------
-------- I-' 
I-' 
TliE ABOVE MODEL IS THE BEST 10 VARIABLE MODEL FOUND. °' 
APPENDIX F 
FIGURES 3 THROUGH 13 
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Figure 3. 
ZINC INTAKE, mg 
Scattergram of Erythrocyte Zinc Concentration and Zinc 
Intake for Pre-Menarcheal Subjects 
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Figure 4. 
ZINC INTAKE, mg 
Scattergram of Erythrocyte Zinc Concentration and Zinc 
Intake for Post-Menarcheal Subjects 
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Figure 5. 
ZINC INTAKE, mg 
Scattergram of Plasma Ribonuclease and Zinc Intake for Pre-
Menarcheal Subjects 
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Figure 6. 
ZINC INTAKE, mg 
Scattergram of Plasma Ribonuclease and Zinc Intake for Post-
Menarcheal Subjects 
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Figure 7. 
ZINC INTAKE, mg 
Scattergram of Serum Alkaline Phosphatase and Zinc Intake for 
Pre-Menarcheal Subjects 
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Figure 8. 
RNase, units/min/ml 
Scattergram of Serum Alkaline Phosphatase and Plasma Ribonuclease 
for Pre-Menarcheal Subjects 
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Figure 9. 
RNase, unlts/miu/ml 
Scattergram of Serum Alkaline.Phosphatase and Plasma Ribonuclease 
for Post-Menarcheal Subjects 
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Figure 10. 
EZN, µg/g 
Scattergram of Serum Alkaline Phosphatase and Erythrocyte Zinc 
Concentration for Pre-Menarcheal Subjects 
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Figure 11. 
EZN, 11g/g 
Scattergram of Serum Alkaline Phosphatase and Erythrocyte Zinc 
Concentration for Post-Menarcheal Subjects 
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Figure 12. 
EZN, µg/g 
Scattergram of Plasma Ribonuclease and Erythrocyte Zinc Concen-
tration for Pre-Menarcheal Subjects 
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Figure 13. 
EZN, µg/g 
Scattergram of Plasma Ribonuclease and Erythrocyte Zinc Concen-
tration for Post-Menarcheal Subjects 
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APPENDIX G 
STEPWISE REGRESSION MODELS WITH 
"FORCED" VARIABLES 
• 
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I/ARNING: 
Sl£P 0 
STEP 2 
MAXIMUM ft-SQUARE IMPROVEMENl FOR OEPENOlNT VARIABLE EZN 
lllE FIRST 1 VARIABLES IN EAClt HOOEL ARE INCLUDED VARIABU:S. 
3 08SfRVATIONS OELEfEO OUE TO HISSING VALUES. 
INCIUOlO VARIABLE EN1£R[IJ 
REGRESSION 
ERROR 
TOTAL 
INTERCEPT 
ZN 
VAlllAOLE AG[ rnrrnrn 
REGRESSION 
ERROR 
lOTAL 
IHTLRCEPT 
ZN 
AGE 
R SQUARE = 0.02173409 
OF 
1 
133 
1311 
B VALUE 
8.061J75299 
-O.Olf77881J1 
SUM Of SQUARES 
9.48270078 
426.8227B070 
IJ36.3051J8148 
STD ERROR 
0.02780062 
H SQUARE= 0.19001068 
Of SUH OF SQUARES 
2 82.90270208 
132 353. IJ02779111 
134 1136.3054811J8 
I.I VALUE SH> ERfWH 
O.IJ8589599 
-0.01723706 0.0260540'1 
0. 043561125 0.00831900 
C(PI 
G( Pl = 
28.36551612 
HEAN SQUARE 
9.IJ8270078 
3.20919384 
lYPE II SS 
9.'18270078 
2.95222674 
HEAN SQUARE 
41,11513510'1 
2.67729378 
TYPE 11 SS 
1.171851119 
73.42000130 
lHE Al.IOVE MOUH IS THE BEST 2 VAiii ABLE HODEL fOUND. 
SfEP 3 VARIABLE E ENTER[() R SQUARE = 0.20306463 C( P) = 2.82565716 
Of SUH OF SQUARES HEAN SQUARE 
RlGllESSION 3 88. 59821331 29. 53273777 
ERROR 131 3117. 70726817 2.651125396 
lOTAL 134 436. 3051J81•18 
8 VALUE SH> ERROR TYPE 11 SS 
I NI LRCEPT 1. 33887058 
lN o. 01787301 0.03531924 0.67969665 
AGl 0.04111111511 0.00840893 64. l1663481J5 
£ -0.0004683'1 0.00031971 5.695511211 
HIE ABOVE HOllt:I. IS I It[ llES r 3 VAii i.A.OLE HOOCL FOUND. 
F 
2.95 
F 
2.95 
F 
15.IJB 
F 
0.44 
27.42 
f 
11. 13 
f 
0.26 
211.29 
2.15 
PROB>f 
0.0619 
PROO>F 
0.0879 
PROO>f 
0.0001 
PROB>f 
0.509'• 
0.0001 
PROB>f 
0.0001 
PllOB>F 
0.6137 
0.0001 
0.1454 
...... 
w 
0 
MAXIMUM R-SQUARE IMPROVEMENf FOR DEPENDENT VARlllRLE EZN 
HIE r I RST 1 VARIABLES IN EACll MODH ARE INCLllOED VllRIARLES. 
STEP 11 VllR I llBLE PRO ENTERED R SQUARE = 0.22212090 C( P) = 1. 72 12111111 
Of SUM OF SQUARES MEAN SQUARE 
llEGRESSION II 96.9125671111 211. 228111166 
ERROR 130 339.392914011 2.610711172 
IOTl\L 1311 1136. 3051t81118 
B VALUE STD ERROR TYPE II SS 
INIERCEPT 1.01739631 
ZN -0.02131t285 o. 0111350711 0.69550128 
llGE 0. 01126251!0 0.00836602 67. 773311080 
PRO 0.0233061t2 0.01305993 8.3111351t13 
E -0.00098909 0.0001t3092 13.751122057 
THE ABOVE MODEL IS THE BEST II VAR I ABLE MODEL FOUND. 
SIEP 5 VARIABLE Riil ENHRED 
REGRESSION 
ERROR 
TOTAL 
I NIERCEPT 
ZN 
RllT 
AGE 
PllO 
E 
R SQUARE = 0.230511176 
or SUM OF SQUARES 
5 100. 5 71185187 
129 335.73062962 
131t lt36. 305118 llt8 
B VALUE STD ERROR 
6. 33908710 
-0.0120ltll13 0. 011202369 
-0.0119113286 O.Olt167162 
0.0110600112 0.00852559 
0.02257200 0.013051122 
-0.00103866 0.000113227 
THE ABOVE MODEL IS TllE BEST 5 VARIABLE MODEL fOUND. 
C(P) = 2.353861t61 
MEAN SQUARE 
20.111t97031 
2.60256302 
TYPE II SS 
0.21377836 
3.6622811113 
59.02190131 
7. 78107560 
15.02559897 
f 
9.28 
f 
0.27 
25.96 
3. 18 
5.27 
F 
7.73 
F 
0.08 
1. 111 
22.68 
2.99 
5. 77 
PROB>F 
0.0001 
PROB>f 
0.6066 
0.0001 
0.0767 
0.0233 
PROB>F 
0.0001 
PROB>F 
o. 771t9 
o. 2371 
0.0001 
0.0662 
0.0177 
I-' 
w 
I-' 
MAX I MllH R-SQllAll! IHPRllVl.ME.N 1· fOR IJF l'lNUrtH VAR IADU Rll/\S[ 
TllE FIRST 1 VARIABLES IN EACH MOUll ARE INGLllOFO VARIAOl.FS. 
WARNING: 3 OllSfRVAl IONS OflfHll 011£ TO HISSING VALUES. 
ST£P 0 INGUJO[O VARIABLE ENIERrn R SQUARE = 0.013668117 G(P) = 7. 36365375 
Of SUM or SQUARES HEAN SQUARE f PROO>F 
REGRESSION I 1.02725532 1.02725532 1.811 O.Hli9 
ERROR 133 71l.13007801 0.55136901 
lOlAI. 1311 75.15733333 
8 VALUE STD ERROR TYPE II SS f PROB>f 
INTERGErl 5.32729794 
LZN -0.04852258 0.03574177 1,02725532 1.811 o. 1769 
STfP 2 VARIABLE AG£ fNIEHEO R SQUARE = 0.03361175 G(P) = 6.56593330 
Of SUH or SQUARES MEAN SQUARE r PROB>F 
REGRESSION 2 2.526169115 t. 263081172 2. 30 o. 1047 
lRl!OR 132 72.63116389 0.55023609 
TOlAL 1311 75.15733333 
8 VALUE STD ERROR TYPE II SS r PROll>f 
INIERGEPT 6.23611651 
£ZN -0.02038205 0.03939315 0. 14730023 0.27 0.6057 
AGE -0.00672950 0.00407726 1 • 1!98911113 2.72 0.1012 
HIE ABOVE HOOH IS HIE DES I 2 VARIABLE HODEL FOUND. 
SlEP 3 VARIABLE AP ENlEREO R SQUARE = 0.061127967 G(P) = 11.26360651 
or SUH OF SQUARES MFAN SQUARE r PROB>f 
REGRESSION 3 lt.83108830 1. 61036277 3.00 0.0.126 
ERROR 131 70. 326211503 0. 53681115 7 
TOTAL 1311 75. 15733333 
8 VALUE STO ERROR TYPE 11 SS r PROB>f 
INTERCEPT 7.6623520lj 
EZN -0.016811205 0.0389'l821 0.10036319 0.19 0.6661 
AP -0.09120261! 0.041101520 2. 301191886 11.29 O.Olt02 
AGE -0.013112855 0.0051611~8 3.629511127 6. 76 O.OIOIJ 
-----------------------------------------------------------------·-----------------------------------------------
1-1 
w 
N 
MAX I MUM ll- SCllJAIU I MPllOVl .. HrN I I Oii IJU'lNl>l U I V/\H I AUi.i. HNll:it 
HIE r I RSl 1 VAlllAlll.ES IN EACll MODH ARE INCLUOEO VAlllABUS. 
snr 3 AG£ RlPLACrn BY MENS 11 SQUAil£ = 0.06881905 C( Pl = 3.62101761 
or SUM Of SQllAllES MEAN SQUARE f PR08>f 
REGllESSION 3 5. 17225601 1 . 721!08534 3.23 0.02114 
EllROR 131 69. 98507732 o. 531123123 
TOTAL 1311 75. 15733333 
B VALUE SlD ERROR TYPE 11 SS f PROB>f 
IN fERCEPl 11. 911195306 
EZN -o. 03756 729 0.03666334 0.56090555 1.05 0. 3074 
AP -0.10479346 0.04636692 2.72869006 5.11 0.0255 
HENS 0.53136195 0. 19490523 3 .97070698 7.43 0.0073 
111[ ABOVE MODEL IS HIE BF.SI 3 VARIABLE HODEL roUNO. 
STFP 11 VARIABLE PRO ENTERED R SQUARE = 0.09140218 C( Pl = 2, 115903257 
Of SUH Of SQUARES HFAN SCIUARE F PROO>f 
REGRfSSION 4 6. 8695111!08 1. 71738602 3.27 0.0137 
ERROR 130 68. 28 778925 0.52529069 
fOTAL 1311 75. 15733333 
B VALUE STD ERROR TYPE 11 SS F PROB>F 
INHRCEPI 5. 17628674 
EZN -0.04069270 0.03639661 0.65661505 1.25 0.2656 
Al' -o. 09111! 1332 0. 011633827 2.18065373 4.15 0.0436 
PRO -0.001!95181 0.00275478 1.69728807 3.23 0.07116 
MENS 0.58351124 0. 195113171 lj,6828261!9 8.91 0.00311 
----------------------------------------------------------------------------------------------------t------------
THE ABOVE HODEL IS THE BEST 4 VARIABLE HOOEL FOUND. 
STEP 5 VARIABLE AGE ENTERED R SQUARE= 0.11564109 C( Pl = 1.05066118 
OF SUH Of SQUAllES HEAN SQUARE F PROB>F 
REGRESSION 5 8. 69133607 1.73826721 3. 37 0.0069 
ERROR 129 66.46599726 0.515211029 
TOTAL 1311 75. 15733333 
B VALUE STO ERROR TYPE 11 SS F PROll>f 
INHRC£PI 6. 98497379 
EZN -0.016911656 0.038191!82 o. 101429119 0.20 0.6580 
AP -o. 127011845 0.011906496 3.45466264 6.70 0.0107 
PRO -o. 00513624 0.00273006 I. 82371806 3. 511 0.0622 
AGE -o.01011ro6 0.00538779 1.82179199 3. 511 0.0623 
MENS 0.45434952 0.20538019 2.52158058 4.89 0.0287 
THE A80VE HODEL IS THE BEST 5 VARIABlf HODEL rDllND. 
,_.. 
w 
w 
WARNING: 
SlEP 0 
STEP 3 
MM<IMUM fl-SQUARE IMPROVEMEN I I Oil DlPENDlN.I Vl\H 11\0LE llNl\Sf_ 
lllf FIRST 2 VARIABUS IN EACll MOOfl ARE INCUJll[f) VARIAOl.£5. 
3 OBSERVAllONS nrLHEO DU£ ro MISSING VALUES. 
INCLUOEO Vl\RIAllLES ENTERED 
REGRESSION 
ERROR 
1011\I_ 
INHRCEPI 
EZN 
ZN 
VARIABLE AGE F.Nf£R£0 
REGRESSION 
£RROR 
TOIAL 
INTERCEPT 
£ZN 
ZN 
AGE 
R SQUARE = 0.02929632 
or 
2 
132 
1311 
0 VALUE 
5.56202058 
-0.05625629 
-0.01700470 
SUH or SQUARES 
2,20183336 
72. 955119998 
75. 15733333 
STD ERROR 
0.03598lt73 
0. 011661161 
R SQUARE = 0.05697722 
OF SUH Of SQUARES 
3 4.28225592 
131 70.87507741 
1311 75.15733333 
B VALUE STD £RROR 
6.7071!2823 
-0.021!43453 0.03912696 
-0.021l3581 0.01173159 
-0.00805912 0.00410982 
C(P) 
C( P) = 
7. 17130601 
HEAN SQUARE 
1.10091668 
0.55269318 
TYPE II SS 
1.35079585 
1. 17lt5760ll 
5.288201111 
MEAN SQUARE 
t. lt27lt186lt 
0. 511103113 
TYP£ II SS 
0.21099775 
1.75606648 
2.0801!2256 
TllE ABOVE MODEL IS Tiff BEST 3 VARIABLE MODEL FOUND, 
SHP 4 VARIABLE AP ENTERED R SQUARE = 0.082851101 C( P) = 3.65617866 
OF SUM Of SQUARES MEAN SQUARE 
REGllESSION 11 6.22706639 1. 55617160 
ERROR 130 66.930211691! 0.53023267 
IOTAL 1311 75.15733333 
B VALUE STD ERROR TYPE II SS 
INTERCEPT 1. 971181460 
lZN -0.02071!525 0.038782110 0.15171707 
ZN -0.01893655 0.01167056 1.39599609 
AP -0.084181t68 o.0•1395674 1. 91111830'l7 
AGE -0.011tl01t3lt 0. 005149116 3.97785113 
f 
1.99 
F 
2.4lt 
2. 13 
F 
2.611 
F 
0.39 
3.25 
3.85 
f 
2.9lt 
f 
0.29 
2.63 
3.67 
7.50 
PROB>f 
o. 11105 
PROB>f 
0.120lt 
o. 1473 
PROB>F 
0.0514 
PROB>F 
0.533lt 
0.0739 
0.0520 
PROB>F 
0.0231 
PROB>f 
0.5936 
0.1071 
0.0571 
0.0070 
I-' 
w 
+:-
SHP 11 AGE HEPLACED OY HENS 
REGRESSION 
ERROR 
TOI AL 
INTERCEl'l 
EZN 
ZN 
AP 
HENS 
MAXIMUM R-SQIJAllf: IMl'ROVtMENI FOR IJ[PENOUH VAlllABL£ HNAS[ 
lllE r I RS r 2 VARIABLES IN EACll MOIJLL ARE INCUJDrn VARIABLES. 
ll SQIJARE = 0.08653425 C( P) = 3. 111191061 
or SUH Of SQUARES HfAN SQUARE 
11 6.50368353 1.62592088 
130 68.65361t980 0. 52610500 
1311 75.15733333 
B VALUE STD ERROR TYPE I I SS 
5. 11913658 
-0.04256362 0.03658696 0. 71532809 
-0.018470911 0.01163296 1. 3311t2751 
-0.09760641t o.0•1632112 2.31t•181113 
0. 551156114 o. 191116398 It. 251t41t827 
111£ ABOVE HOIJEL IS HIE BESI 11 VARIABLE MODEL FOUND. 
ST£P 5 VARIABU /\GE FNHRED R SQUARE= 0.11177335 C(P) = 1. 6013111101 
or SUH or SQUARES HEAN SQUARE 
RfGRESSION 5 6.lt0058686 1.68011738 
lRROR 129 66.756711646 o. 5171t9416 
TOlAt 1311 75. 15733333 
ll VALUE STD ERROR TYPE 11 SS 
INTERCEPT 6. 97159119 
£ZN -0.01857862 0.03632829 o. 12158884 
ZN -0.01985893 0.01153830 1. 53296887 
AP -0.13080688 o. 011902346 3. 681133140 
AGE -0.01035158 0.00540676 1. 89690335 
HENS 0.41868616 0.20429675 2. 17 3500119 
fllE ABOVE MODEL IS 111E BEST 5 VARIABLE MODEL FOUNO. 
f 
3.08 
F 
1. 35 
2.52 
lt.41t 
6.06 
r 
3.25 
r 
0.23 
2.96 
1. 12 
3 .6 7 
•1.20 
Pnoo~r 
0.01115 
PROB>F 
o. 21166 
o. 11'18 
0.0370 
0.0053 
PROB>F 
0.0087 
PROB>f 
0.6287 
0.0876 
0.0066 
0.0578 
0.011211 
...... 
w 
\.J1 
WARNING: 
SIEr 0 
STEP 11 
MllX I MUM l<-Sl.lllAHl I Ml'llllVLMHll I OH IJU'LNULN I VAH I AULL HNA!;t 
rnr rlRST 3 VARIABLES IN EAGH MO!J[L ARE INCLUDED VARIABLES. 
3 OBSERVATIONS llEUlfll IJIJE lO MISSING VALUES. 
INCLIJDFD VARIABI [S rnrrnrn 
REGRESSION 
£RHOR 
TOTAL 
IN ffRCEP I 
EZN 
ZN 
Al' 
VARIABLE MENS ENTERED 
REGRESSION 
ERROR 
lOTAL 
INffRCEPT 
EZN 
ZN 
AP 
HENS 
R SQUARE = 0.02992"102 
Of 
3 
131 
1311 
B VAl.UE 
5.61238030 
-0.05874556 
-0.01635119 
-0.01038421 
SUM or SQUARES 
2.24923'i26 
72.90809807 
75. 15733333 
STD ERROR 
0.03710379 
0.01191751 
0.03556179 
R SQUARE = 0.08653425 
or SUH OF SQUARES 
11 6.50368353 
130 68.653611980 
1311 75. 15133333 
B VALUE STD ERROR 
5.11913858 
-0.04258362 0.03658896 
-0.01847094 0.01163296 
-0.091606114 0.04632172 
0.551156li4 0. 19418398 
C( P) 
C( P) = 
9.06263045 
MEAN SQUARE 
0. 7119111509 
0.55655037 
TYPE II SS 
1. 39511!06 7 
1. 011768823 
0.04740190 
3.111191061 
MEAN SQUARE 
1. 62592088 
0. 52810500 
TYPE 11 SS 
o. 71532809 
1. 33142751 
2.341181113 
lj. 2511114827 
r 
1. 35 
2.51 
1.88 
0.09 
f 
3.06 
f 
1. 35 
2.52 
4.411 
8.06 
rnoB>f 
0.2611 
PROB>r 
0. 1158 
0. 11211 
0. 1709 
PROB>r 
0.0185 
PROB>r 
0.2466 
0.1 lli8 
0.0310 
0.0053 
-----------------------------------------------------------------------------------------------------------------
THE ABOVE HODEL IS lltE BEST 4 VARIABLE HODEL FOUND. 
STEP 5 VARIABLE AGE ENTE.RED R SQUARE= 0.11177335 C( P) = 1.60134401 
or SUH OF SQUARES HEAN SQUARE F PROO>F 
REGRESSION 5 8.40058688 1. 68011738 3.25 0.0067 
ERROR 129 66.75674646 0.51749416 
TOTAL 1311 75. 15733333 
B VALUE STD ERROR TYPE II SS F PROO>f 
INTERC:f PT 6.97159119 
EZN -0.01657862 0.03832829 0.121588611 0.23 0.6287 
ZN -0.01965893 0.01153630 1.53296667 2.96 0.0876 
AP -0. 13080688 0.0119023116 3. 68433140 7. 12 0.0086 
AGE -0.01035158 0.00540676 1.89690335 3.67 0.0578 
HENS 0.41868616 0.201129675 2. 173500119 11.20 0.011211 
THE ABOVE HODEL IS THE BEST 5 VARIABLE HODEL FOUND. 
...... 
w 
0-. 
WARNING: 
SrEP fl 
STEP 2 
Ml\XIMUM l<-~qlll\l<L IMl'l<OVIMLlll IUI< lll.l'LNlllNI VAl<ll\UU Al' 
fll[ rtnST I VARIABLES IN EACll MOOEL AllE INCLUllf.O VARIABLES. 
2 OllSrRVAllONS on [f[I) DOE 10 MISSING VALUES. 
INCLUUEO VARIABLE ENfrRED R SQUAii£ = 0.059911f70 C( P) = 171.1171119092 
or SUH or SQUARFS HEAN SQUARE 
REGRESSION 1 29. 537111f305 29. 5371flf305 
EHR OR 131f l163.lf51f16798 3.lf5861319 
TOTAL 135 1192.99161103 
B VALUE SID ERHOR TYPE 11 SS 
INHRCEPT 5.63193122 
£ZN -0.25963685 0.08081flf57 29. 5371Jlf305 
VAR I ABLE MENS ENIERrD R SQUARE = 0. 11903211118 C( P) = 37.78269193 
or SUM or SQUARES MEAN SQUARE 
REGRESSION 2 21i 1. 725855 79 120.86292190 
ERROR 133 251 • 265 755211 1.88921620 
lOTAL 135 1192.99161103 
8 VALUE STD ERROR TYPE 11 SS 
INT£RCEPf 0. 36779731i 
EZN -o. 052853111 0.06850063 1. 121f701176 
M[NS 2.85981907 0. 269811760 212.188111271f 
HIE ABOVE MOOEl. IS TllE OEST 2 VARIABLE MODEL FOUND. 
STEP 3 VARIABLE AGE ENTERED R SQUARE= 0.55503320 C( P) = 18.116089713 
OF SUH OF SQUARES MEAN SQUARE 
REGRESSION 3 273.62671218 91. 208901106 
ERROR 132 219.36489885 1.66185529 
TOI Al 135 1192. 99161103 
8 VALUE STD ERROR TYPE II SS 
INTERCEPT 7.32665391 
EZN 0.04826672 0.06826646 0.83075698 
AG[ -0.03952929 0.00902221f 31.90065639 
HENS 1. 9811111608 0.3221f9107 62.90788879 
THE ABOVE MODEL IS Tiil RfSf 3 VARIABLE MOOEL FOUND. 
PROB>r 
8. 511 0. 00111 
PROB>f 
8.51f 0.00111 
F PROll>F 
63.98 0.0001 
F PROB>F 
0.60 0.41117 
112.32 0.0001 
F PROB>F 
511.88 0.0001 
F PROll>F 
0.50 0.11808 
19.20 0.0001 
37 .85 0.0001 
..... 
LV 
-.J 
l•l,\XIMllM 11-SQllAHl IMl'ROV[MUll I OB IJ[PUWLNI VAlllAllU Al' 
THE f IRST 1 VARIAllLES IN fACll MOIJEL ARE INCLUOfD VARIAIJLfS. 
51 EP 11 VAR I ABLE VO fNlUffD n SQUARE = 0.58519832 Cl I') = 10. 551166733 
Df SUH Of SQUARES MEAN SQUARE 
R£Gll£SSION 11 288.49786269 72. 1211116567 
ERROR 131 204.49374834 1.56102098 
TOTAL 135 492.99161103 
B VALUE STO ERllOR TYPE II SS 
INTERCEPT 6.78789795 
fZN 0.03870028 0.06623555 0.53291109 
vu 0.00181163 0.00058695 14.87115051 
AGE -o. 03176852 0.00876263 26. 99676739 
MENS 1 . 898481195 0. 313781105 57.111277411 
TllE AflOVE MOOEL IS TllE BEST 11 VARIABLE HOOEL fOUNO. 
STEP 5 VAR IABI E RNAS[ [NJ mm R SQUARE = 0.608309112 G(PI = 4.942626BB 
OF SUM or SQUARES HEAN SQUARE 
REGRESSION 5 299.69143989 59.97828198 
ERROR 130 193.10017114 1 .116538593 
TOTAL 135 1192.99161103 
B VALUE STO ERROil TYPE II SS 
INHRCEPT 9.011256101 
EZN 0.03098332 0.061167105 0.311093800 
RN ASE -o. 396978511 o. 1433361111 11. 39357720 
VO 0.00177625 0.00057270 llt.28887800 
AGE -0.03952546 0.008571111 31.58553165 
MENS 1. 95511211911 0.30677757 60. 311959868 
THE ABOVE MODH IS TllE BEST 5 VARIABLE MODEL FOUND. 
r 
116.20 
r 
o. lit 
9.53 
18.58 
36.61 
f 
110. 38 
F 
0.23 
7.67 
9.62 
21.26 
40.63 
PRO!l>f 
0.0001 
PRO!l>f 
0.5600 
0.0025 
0.0001 
0.0001 
PflOB>f 
0.0001 
PROB>f 
0.6327 
0.00611 
0.0024 
0.0001 
0.0001 
f-' 
w 
00 
WARNING: 
STEP 0 
STEP 3 
MAXIMUM R-SQUARF. IMPROVFMENT fOR DEPfNOENf VARIABLE AP 
lllE FIRST 2 VARIABLES IN EAClt MODEL ARE INCLUDED VARIABLES. 
2 OBSfRVAflONS OlLETfD DUE TO MISSING VALUES. 
INCl.llOEO VARIABLES ENlEREO 
REGRESSION 
£RROR 
TOlAL 
INlfHCEPT 
EZN 
RNA SE 
VAR I ABLE MENS ENIEREO 
REGRESSION 
ERROR 
TOTAL 
INTERCEPT 
£ZN 
RNllSE 
HENS 
R SQUARE = 0.06187657 
Of 
2 
133 
135 
[l VALUE 
6.23977115 
-o. 26512173 
-o. 114201164 
SUM Of SQUARES 
30.501f62865 
lf62.lf8698238 
li92.99161103 
STO ERROR 
0.08968986 
0.216511731 
R SQUARE= 0.5090801f1 
Of SUM Of SQUARES 
3 250. 91236980 
132 2112.0192ti123 
135 1192.99161103 
8 VALUE STD ERROR 
2.11121911 
-0.06391119 0.06766200 
-0.35658821i 0. 15878738 
2.94373967 0.26845089 
C(P) 
Cf P) = 
178.82565279 
MEAff SQUARE 
15.25231432 
3.1177311573 
TYPE II SS 
30.384118281 
0.96718560 
33.60833280 
MEAff SQUARE 
83.65745660 
1.83347910 
TYPE II SS 
1.63583761 
9.246511100 
220. •16774115 
THE ABOVE MODEL IS HIE BEST 3 VARIABLE MODEL FOUND. 
r 
... 39 
F 
8. 711 
0.28 
r 
li5.63 
r 
0.89 
5.011 
120.25 
PllOB>f 
0.01113 
PROB>F 
o. 0037 
0.5988 
PHOB>F 
0.0001 
PllOB>F 
o. 3•166 
0.02611 
0.0001 
...... 
(.;.) 
\D 
MAXIMUM R-SQllARf IMPROVEMENT FOR 0£PENOfNT VARIAOLE AP 
lllE FIRST 2 VARIABLES IN EACH MODEL ARE INCLUDED VARIABLES. 
STEP II VARIABIE AGE ENlfllED R SQUARE = 0.579325110 C( P) = 12 .11e11021125 
Of SUM Of SQUARES MEAN SQUARE 
REGllESSION II 285.60256189 71 • 11006110117 
ERROR 131 207.3890119111 1.58312251 
TOTAL 135 1192.99161103 
B VALUE STD ERROR TYPE 11 SS 
INTERCEPl 9.62685259 
EZN 0.011016550 0. 066691180 0.571116535 
RNA SE -0.11068911711 0.1117911019 11. 975811911 
AGE -o. 0111291188 0.00882930 311.63019209 
MENS 2.0110793711 0.315113227 66.267118750 
HIE ABOVE MODEL IS THE BEST II VARIABLE HODEL FOUND. 
STEP 5 VARIABLE VO ENTERED R SQUARE = 0.608309112 C(PJ = 11.911262688 
OF SUM OF SQUARES MEAN SQUARE 
REGRESSION 5 299.891113989 59.97828798 
ERROR 130 193.100171111 1 , 118538593 
TOTAL. 135 1192. 99161103 
8 VALUE STD ERROR TYPE 11 SS 
INTERCEPT 9.011256101 
EZN 0.03098332 0.061167105 o. 311093800 
RNA SE -0.396978511 o. 11133361111 11. 39357720 
VO 0.00177625 0.00057210 111.28887800 
AGE -o. 039525116 0.008571111 31. 58553165 
MENS 1 • 95511211911 o. 30677757 60.311959868 
THE ABOVE MODEL IS HIE 0£ST 5 VARIABLE HODEL FOUND. 
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0.36 
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21.87 
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F 
110.38 
f 
0.23 
7.67 
9.62 
21.26 
110.63 
PROB'>r 
0.0001 
PROD>F 
U.51181 
0.0068 
0.0001 
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PROO>f 
0.0001 
PROD>F 
0.6327 
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.p... 
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WARNING: 
SlEP 0 
STEP It 
M/\XIMIJM 11-SQU/\11£ IMPROVFMl.NT !OR l)[PENOUH VATllAllU AP 
lllf FIRST 3 VATllABl.[S IN [ACll Moon AR£ INCUJOEO VARIABUS. 
2 OllS£RVAllONS on [ff() 011£ TO HISSING VALUES. 
INClll0£0 VARIAIJIES F.NHllEO 
REGllESSION 
ERROR 
TOTAL 
INT£RC£PT 
EZN 
RNAS[ 
ZN 
VARIABLE HENS ENTERED 
REGRESSION 
ERROR 
TOTAL 
INTERCEPT 
EZN 
RNA SE 
ZN 
HENS 
R SQUARE = 0.09586115 
OF 
3 
132 
135 
B VALUE 
5.03931456 
-0.23372112 
-0.05461288 
0.06459372 
SUH or SQUARES 
117. 26170202 
4115. 72990901 
119::>.99161103 
STD ERROR 
0.06949969 
0.21506202 
0. 028996111 
R SQUARE= 0.51187641 
OF SUH OF SQUARES 
4 252.35077674 
131 240. 61!083429 
135 492.99161103 
B VALUE STD ERROR 
1.82596038 
-0.05794003 0.06607595 
-0.33527572 0. 16083075 
0.01690066 0.02161935 
2.69667429 0.27414316 
C(P) 
C( P) = 
169.63611813 
MEAN SQUARE 
15.75390067 
3. 37674173 
TYPE II SS 
23.02760638 
0. 21775119 
16. 75707337 
34.66790165 
HEAii SQUARE 
63. 08 7691118 
1. 83695293 
TYPE II SS 
1. 33066271 
7.98296152 
1. 37840694 
205.08907472 
THE ABOVE MODEL IS TllE BESl 11 VARIABLE MODEL FOUND. 
STEP 5 VARIABLE AGE ENTERED R SQUARE= 0.57995525 C( Pl = 14.27667662 
OF SUM OF SQUARES HEAN SQUARE 
REGRESSION 5 265.91307548 57.18261510 
ERROR 130 207.07653554 1. 59291161 
TOTAL 135 492.99161103 
II VALUE STD ERROR TYPE II SS 
INHRCEPT 9.41531464 
EZN 0.0419711tlt 0.06702561 0.62462260 
RNAS[ -0.39621604 0.15035427 11. 06187426 
ZN 0.00902103 0.020lt3201t 0.31051360 
AGL -0. Oll068065 0.00690611 33.56229875 
MENS 2.02736773 0. 31785959 64.80294119 
Tit[ ABOVf HODEL IS Tiff !!EST 5 VARIABLE MODEL FOUND. 
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